Table 1: Univariate analysis of some variables by year (2021 vs 2020, full descriptive table).
Variable | Details | 2021 | 2020 | Total | Statistics |
Year | 113 (51.1%) | 108 (48.9%) | 221 | ||
Age (years) | μ ±SD | 62.75 ±12.2 | 65.22 ±13.9 | 63.96 ±13.1 | T-test: p=0.162 |
Sex | F | 53 (46.9%) | 42 (38.9%) | 95 (43.0%) | OR=1.39 [0.81, 2.37] (p=0.277) |
M | 60 (53.1%) | 66 (61.1%) | 126 (57.0%) | ||
Length of stay (days) | M (IQR) | 12 (9-17) | 12 (8-18) | 12 (8-17) | MW: p=0.647 |
Lung damage >40% | 74 (65.5%) | 68 (63.0%) | 142 (64.3%) | OR=1.12 [0.64, 1.94] (p=0.779) | |
WHO CPS | ≥6 | 87 (77.0%) | 64 (59.3%) | 151 (68.3%) | OR=2.30 [1.28, 4.12] (p=0.006) |
<6 | 26 (23.0%) | 44 (40.7%) | 70 (31.7%) | ||
Deceased | 11 (9.7%) | 14 (13.0%) | 25 (11.3%) | OR=0.72 [0.31, 1.67] (p=0.526) | |
ICU admission | 25 (22.1%) | 40 (37.0%) | 65 (29.4%) | OR=0.48 [0.27, 0.87] (p=0.018) | |
Sepsis/Pneumonia | 3 (2.7%) | 8 (7.4%) | 11 (5.0%) | OR=0.34 [0.09, 1.32] (p=0.129) | |
Cardiovascular comorbidities (>2) | 21 (18.6%) | 27 (25.0%) | 48 (21.7%) | OR=0.68 [0.36, 1.30] (p=0.258) | |
High blood pressure | 74 (65.5%) | 77 (71.3%) | 151 (68.3%) | OR=0.76 [0.43, 1.35] (p=0.387) | |
Atrial fibrillation | 9 (8.0%) | 10 (9.3%) | 19 (8.6%) | OR=0.85 [0.33, 2.18] (p=0.813) | |
Chronic kidney disease | 6 (5.3%) | 7 (6.5%) | 13 (5.9%) | OR=0.81 [0.26, 2.49] (p=0.780) | |
Diabetes mellitus II | 37 (32.7%) | 39 (36.1%) | 76 (34.4%) | OR=0.86 [0.49, 1.50] (p=0.671) | |
Obesity | 60 (53.1%) | 43 (39.8%) | 103 (46.6%) | OR=1.71 [1.00, 2.92] (p=0.059) | |
Admission to TCZ (days) | M (IQR) | 3 (1-4) | 4 (1-7) | 3 (1-6) | MW: p=0.011 |
TCZ >3 days after admission | 42 (37.2%) | 55 (50.9%) | 97 (43.9%) | OR=0.57 [0.33, 0.97] (p=0.043) | |
Day 0: CRP (mg/dL) | M (IQR) | 9.09 (5.33-15.1) | 9.22 (4.77-13.36) | 9.12 (4.85-14.57) | MW: p=0.558 |
Day 3: CRP (mg/dL) | M (IQR) | 2.48 (1.08-4.19) | 1.96 (1.1-3.46) | 2.1 (1.09-3.97) | MW: p=0.355 |
Day 7: CRP (mg/dL) | M (IQR) | 0.39 (0.2-0.54) | 0.42 (0.22-0.73) | 0.39 (0.2-0.63) | MW: p=0.250 |
Day 0: ALT (U/L) | M (IQR) | 42 (26.75-70.75) | 41 (22.75-64) | 42 (25-66.25) | MW: p=0.228 |
Day 3: ALT (U/L) | M (IQR) | 60 (38-96) | 54 (27-106) | 59 (36-101.75) | MW: p=0.610 |
Day 7: ALT (U/L) | M (IQR) | 68 (44-99) | 62.5 (44.75-90.5) | 65 (44-94) | MW: p=0.520 |
μ ±SD = Mean ± standard deviation; M (min:max) = Median (min:max); MW = Mann-Whitney Test; OR = odds-ratio [95% CI] and p value from Fisher test); * custom text |
Table 2: Univariate analysis of some variables by COVID death (full descriptive table).
Variable | Details | yes | no | Total | Statistics |
Deceased | 25 (11.3%) | 196 (88.7%) | 221 | ||
Age (years) | μ ±SD | 68.88 ±13.5 | 63.33 ±13.0 | 63.96 ±13.1 | T-test: p=0.046 |
Sex | F | 9 (36.0%) | 86 (43.9%) | 95 (43.0%) | OR=0.72 [0.30, 1.71] (p=0.524) |
M | 16 (64.0%) | 110 (56.1%) | 126 (57.0%) | ||
ICU admission | 17 (68.0%) | 48 (24.5%) | 65 (29.4%) | OR=6.55 [2.66, 16.13] (p<0.001) | |
Length of stay (days) | M (IQR) | 17 (11-23) | 12 (8-17) | 12 (8-17) | MW: p=0.067 |
Lung damage >40% | 24 (96.0%) | 118 (60.2%) | 142 (64.3%) | OR=15.86 [2.10, 119.68] (p<0.001) | |
Cardiovascular comorbidities (>2) | 12 (48.0%) | 36 (18.4%) | 48 (21.7%) | OR=4.10 [1.73, 9.73] (p=0.002) | |
High blood pressure | 20 (80.0%) | 131 (66.8%) | 151 (68.3%) | OR=1.98 [0.71, 5.53] (p=0.254) | |
Atrial fibrillation | 5 (20.0%) | 14 (7.1%) | 19 (8.6%) | OR=3.25 [1.06, 9.97] (p=0.047) | |
Chronic kidney disease | 5 (20.0%) | 8 (4.1%) | 13 (5.9%) | OR=5.88 [1.75, 19.68] (p=0.009) | |
Diabetes mellitus II | 9 (36.0%) | 67 (34.2%) | 76 (34.4%) | OR=1.08 [0.45, 2.58] (p=0.827) | |
Obesity | 8 (32.0%) | 95 (48.5%) | 103 (46.6%) | OR=0.50 [0.21, 1.21] (p=0.139) | |
Sepsis/Pneumonia | 8 (32.0%) | 3 (1.5%) | 11 (5.0%) | OR=30.27 [7.34, 124.81] (p<0.001) | |
Admission to TCZ (days) | M (IQR) | 5 (2-7) | 3 (1-5) | 3 (1-6) | MW: p=0.023 |
TCZ >3 days after admission | 16 (64.0%) | 81 (41.3%) | 97 (43.9%) | OR=2.52 [1.06, 5.99] (p=0.035) | |
μ ±SD = Mean ± standard deviation; M (min:max) = Median (min:max); MW = Mann-Whitney Test; OR = odds-ratio [95% CI] and p value from Fisher test); * custom text |
Table 3: Univariate analysis of some variables by COVID death (full descriptive table).
Variable | Details | yes | no | Total | Statistics |
Deceased | 25 (11.3%) | 196 (88.7%) | 221 | ||
Day 0: D-dimer (mg/L) | M (IQR) | 1.22 (0.86-3.73) | 0.72 (0.43-1.51) | 0.82 (0.46-1.68) | MW: p=0.002 |
Day 0: CRP (mg/dL) | M (IQR) | 11.11 (5.78-14.57) | 8.9 (4.82-14.54) | 9.12 (4.85-14.57) | MW: p=0.258 |
Day 0: CRP >7.5 mg/dL | 16 (64.0%) | 112 (57.1%) | 128 (57.9%) | OR=1.33 [0.56, 3.16] (p=0.668) | |
Day 0: Ferritin (ng/mL) | M (IQR) | 761 (444.1-1448) | 575.65 (281.88-894.72) | 584 (303.7-938.5) | MW: p=0.075 |
Day 0: ALT (U/L) | M (IQR) | 39 (28-88.5) | 42 (25-65.5) | 42 (25-66.25) | MW: p=0.489 |
Day 3: D-dimer (mg/L) | M (IQR) | 3.79 (1.63-11.68) | 0.94 (0.57-2.13) | 1.03 (0.58-2.57) | MW: p=0.001 |
Day 3: CRP (mg/dL) | M (IQR) | 3.09 (1.49-7.35) | 2.07 (1.08-3.68) | 2.1 (1.09-3.97) | MW: p=0.057 |
Day 3: CRP >7.5 mg/dL | 5 (25.0%) | 5 (3.2%) | 10 (5.6%) | OR=10.13 [2.63, 39.02] (p=0.002) | |
Day 3: Ferritin (ng/mL) | M (IQR) | 716.45 (629.68-935.02) | 676 (352.6-1021.7) | 682.9 (355.7-1021.7) | MW: p=0.372 |
Day 3: ALT (U/L) | M (IQR) | 38.5 (24.75-80) | 61 (38.25-105) | 59 (36-101.75) | MW: p=0.108 |
Day 7: D-dimer (mg/L) | M (IQR) | 3.27 (2.03-5.67) | 1.02 (0.51-2.16) | 1.15 (0.53-2.96) | MW: p<0.001 |
Day 7: CRP (mg/dL) | M (IQR) | 0.74 (0.32-1.59) | 0.38 (0.2-0.57) | 0.39 (0.2-0.63) | MW: p=0.037 |
Day 7: CRP >7.5 mg/dL | 2 (11.8%) | 0 | 2 (1.4%) | OR=41.77 [1.92, 910.50] (p=0.013) | |
Day 7: Ferritin (ng/mL) | M (IQR) | 719.9 (376.97-976.45) | 536.8 (275.4-795.95) | 547.5 (291.45-804.8) | MW: p=0.281 |
Day 7: ALT (U/L) | M (IQR) | 54 (29-70) | 67.5 (45-99.25) | 65 (44-94) | MW: p=0.020 |
μ ±SD = Mean ± standard deviation; M (min:max) = Median (min:max); MW = Mann-Whitney Test; OR = odds-ratio [95% CI] and p value from Fisher test); * custom text |
Table 4: Univariate analysis of all variables by COVID death (full descriptive table).
Main
Variable | Details | yes | no | Total | Statistics |
Deceased | 25 (11.3%) | 196 (88.7%) | 221 | ||
Age (years) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.064 |
μ ±SD | 68.88 ±13.5 | 63.33 ±13.0 | 63.96 ±13.1 | ||
M (min:max) | 71 (45:90) | 64 (24:93) | 65 (24:93) | ||
Sex | F | 9 (36.0%) | 86 (43.9%) | 95 (43.0%) | OR=0.72 [0.30, 1.71] (p=0.524) |
M | 16 (64.0%) | 110 (56.1%) | 126 (57.0%) | ||
Year | 2021 | 11 (44.0%) | 102 (52.0%) | 113 (51.1%) | OR=0.72 [0.31, 1.67] (p=0.526) |
2020 | 14 (56.0%) | 94 (48.0%) | 108 (48.9%) | ||
Length of stay (days) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.067 |
μ ±SD | 17.56 ±12.6 | 13.59 ±7.78 | 14.04 ±8.53 | ||
M (min:max) | 17 (1:55) | 12 (1:46) | 12 (1:55) | ||
M (IQR) | 17 (11-23) | 12 (8-17) | 12 (8-17) | ||
Gμ ±SD | 11.92 ±2.98 | 11.67 ±1.77 | 11.70 ±1.91 | ||
Onset to hospitalization (days) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.529 |
μ ±SD | 7.44 ±5.5 | 7.56 ±4.1 | 7.55 ±4.26 | ||
M (min:max) | 7 (0:28) | 7 (0:35) | 7 (0:35) | ||
M (IQR) | 7 (4-10) | 7 (5-10) | 7 (5-10) | ||
Gμ ±SD | 3.43 ±12.2 | 5.62 ±3.94 | 5.31 ±4.67 | ||
Admission to TCZ (days) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.023 |
μ ±SD | 5.64 ±4.55 | 3.62 ±3.38 | 3.85 ±3.58 | ||
M (min:max) | 5 (0:16) | 3 (0:16) | 3 (0:16) | ||
M (IQR) | 5 (2-7) | 3 (1-5) | 3 (1-6) | ||
Gμ ±SD | 2.99 ±6.65 | 0.894 ±21.0 | 1.02 ±19.2 | ||
TCZ >3 days after admission | 16 (64.0%) | 81 (41.3%) | 97 (43.9%) | OR=2.52 [1.06, 5.99] (p=0.035) | |
Onset to TCZ (days) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.132 |
μ ±SD | 13.08 ±5.84 | 11.11 ±5.08 | 11.33 ±5.2 | ||
M (min:max) | 12 (5:30) | 10 (0:40) | 11 (0:40) | ||
M (IQR) | 12 (9-16) | 10 (8-14) | 11 (8-14) | ||
Gμ ±SD | 11.99 ±1.53 | 9.62 ±2.26 | 9.86 ±2.19 | ||
Lung damage (%) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p<0.001 |
μ ±SD | 76.80 ±12.8 | 49.31 ±21.5 | 52.42 ±22.5 | ||
M (min:max) | 80 (40:90) | 50 (5:90) | 50 (5:90) | ||
M (IQR) | 80 (70-90) | 50 (30-60) | 50 (40-70) | ||
Gμ ±SD | 75.56 ±1.21 | 42.91 ±1.82 | 45.75 ±1.81 | ||
Lung damage >40% | 24 (96.0%) | 118 (60.2%) | 142 (64.3%) | OR=15.86 [2.10, 119.68] (p<0.001) | |
WHO CPS | ≥6 | 25 (100%) | 126 (64.3%) | 151 (68.3%) | OR=28.42 [1.70, 473.98] (p<0.001) |
<6 | 0 | 70 (35.7%) | 70 (31.7%) | ||
Fever | 18 (72.0%) | 151 (77.0%) | 169 (76.5%) | OR=0.77 [0.30, 1.95] (p=0.618) | |
Cough | 18 (72.0%) | 153 (78.1%) | 171 (77.4%) | OR=0.72 [0.28, 1.84] (p=0.459) | |
Dyspnea | 17 (68.0%) | 109 (55.6%) | 126 (57.0%) | OR=1.70 [0.70, 4.12] (p=0.287) | |
Diarrhea | 1 (4.3%) | 25 (12.9%) | 26 (12.0%) | OR=0.31 [0.04, 2.38] (p=0.324) | |
Infections | 0 | 0 | 0 | OR=13.07 [0.25, 682.92] (p>0.999) | |
Sepsis/Pneumonia | 8 (32.0%) | 3 (1.5%) | 11 (5.0%) | OR=30.27 [7.34, 124.81] (p<0.001) | |
ICU admission | 17 (68.0%) | 48 (24.5%) | 65 (29.4%) | OR=6.55 [2.66, 16.13] (p<0.001) | |
Diabetes mellitus I | 0 | 0 | 0 | OR=7.71 [0.15, 396.85] (p>0.999) | |
Diabetes mellitus II | 9 (36.0%) | 67 (34.2%) | 76 (34.4%) | OR=1.08 [0.45, 2.58] (p=0.827) | |
Cardiovascular comorbidities | yes | 21 (84.0%) | 138 (70.4%) | 159 (71.9%) | OR=2.21 [0.73, 6.71] (p=0.236) |
N (%) | 25 (100%) | 196 (100%) | 221 (100%) | ||
μ ±SD | 2.28 ±1.62 | 1.42 ±1.42 | 1.52 ±1.46 | ||
M (min:max) | 2 (0:5) | 1 (0:6) | 1 (0:6) | ||
M (IQR) | 2 (1-4) | 1 (0-2) | 1 (0-2) | ||
Gμ ±SD | 0.673 ±19.2 | 0.188 ±31.1 | 0.217 ±30.1 | ||
Cardiovascular comorbidities (>2) | 12 (48.0%) | 36 (18.4%) | 48 (21.7%) | OR=4.10 [1.73, 9.73] (p=0.002) | |
High blood pressure | 20 (80.0%) | 131 (66.8%) | 151 (68.3%) | OR=1.98 [0.71, 5.53] (p=0.254) | |
Atrial fibrillation | 5 (20.0%) | 14 (7.1%) | 19 (8.6%) | OR=3.25 [1.06, 9.97] (p=0.047) | |
Arrhythmia | 3 (12.0%) | 8 (4.1%) | 11 (5.0%) | OR=3.20 [0.79, 12.98] (p=0.115) | |
Pulmonary embolism | 1 (4.0%) | 13 (6.7%) | 14 (6.4%) | OR=0.58 [0.07, 4.66] (p>0.999) | |
Peripheral artery disease | 1 (4.0%) | 5 (2.6%) | 6 (2.7%) | OR=1.58 [0.18, 14.13] (p=0.519) | |
Aortic aneurysm | 0 | 1 (0.5%) | 1 (0.5%) | OR=2.54 [0.10, 64.09] (p>0.999) | |
Coronary heart disease | 10 (40.0%) | 48 (24.5%) | 58 (26.2%) | OR=2.06 [0.87, 4.88] (p=0.145) | |
Valvulopathies | 5 (20.0%) | 17 (8.7%) | 22 (10.0%) | OR=2.62 [0.87, 7.86] (p=0.085) | |
Congestive Heart Failure | 7 (28.0%) | 17 (8.7%) | 24 (10.9%) | OR=4.07 [1.49, 11.12] (p=0.010) | |
Chronic venous insufficiency | 2 (8.0%) | 14 (7.1%) | 16 (7.2%) | OR=1.13 [0.24, 5.29] (p=0.699) | |
Stroke history | 3 (12.0%) | 11 (5.6%) | 14 (6.4%) | OR=2.28 [0.59, 8.81] (p=0.203) | |
Chronic kidney disease | 5 (20.0%) | 8 (4.1%) | 13 (5.9%) | OR=5.88 [1.75, 19.68] (p=0.009) | |
HD | 0 | 2 (1.0%) | 2 (0.9%) | OR=1.53 [0.07, 32.67] (p>0.999) | |
Chronic obstructive pulmonary disease | 3 (12.0%) | 13 (6.6%) | 16 (7.2%) | OR=1.92 [0.51, 7.27] (p=0.401) | |
Asthma | 1 (4.0%) | 7 (3.6%) | 8 (3.6%) | OR=1.12 [0.13, 9.54] (p>0.999) | |
Cancer | 4 (16.0%) | 25 (12.8%) | 29 (13.1%) | OR=1.30 [0.41, 4.11] (p=0.752) | |
Obesity | 8 (32.0%) | 95 (48.5%) | 103 (46.6%) | OR=0.50 [0.21, 1.21] (p=0.139) | |
Overweight | 4 (16.0%) | 43 (21.9%) | 47 (21.3%) | OR=0.68 [0.22, 2.08] (p=0.610) | |
Dexamethasone | 25 (100%) | 189 (96.4%) | 214 (96.8%) | OR=2.02 [0.11, 36.41] (p>0.999) | |
Anakinra | 8 (32.0%) | 24 (12.2%) | 32 (14.5%) | OR=3.37 [1.31, 8.66] (p=0.015) | |
Antibiotics | 24 (96.0%) | 194 (99.0%) | 218 (98.6%) | OR=0.25 [0.02, 2.83] (p=0.304) | |
Remdesivir | 17 (68.0%) | 99 (50.5%) | 116 (52.5%) | OR=2.08 [0.86, 5.05] (p=0.136) | |
Hydroxychloroquine | 12 (48.0%) | 119 (60.7%) | 131 (59.3%) | OR=0.60 [0.26, 1.38] (p=0.280) | |
Favipiravir | 9 (36.0%) | 89 (45.4%) | 98 (44.3%) | OR=0.68 [0.29, 1.60] (p=0.401) | |
μ ±SD = Mean ± standard deviation; M (min:max) = Median (min:max); MW = Mann-Whitney Test; OR = odds-ratio [95% CI] and p value from Fisher test); * custom text |
Admission
Variable | Details | yes | no | Total | Statistics |
Deceased | 25 (11.3%) | 196 (88.7%) | 221 | ||
IL6 (pg/mL) | N (%) | 23 (92.0%) | 167 (85.2%) | 190 (86.0%) | MW: p=0.499 |
μ ±SD | 91.82 ±97.2 | 75.41 ±81.1 | 77.40 ±83.1 | ||
M (min:max) | 51.83 (7.14:346.22) | 50.11 (1.33:514.67) | 50.25 (1.33:514.67) | ||
M (IQR) | 51.83 (29.33-107.44) | 50.11 (18.37-99.95) | 50.25 (19.29-102.48) | ||
Gμ ±SD | 55.45 ±2.93 | 43.44 ±3.19 | 44.74 ±3.16 | ||
IL6 >150 pg/mL | 4 (17.4%) | 23 (13.8%) | 27 (14.2%) | OR=1.32 [0.41, 4.22] (p=0.749) | |
WBC (*1000/uL) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.037 |
μ ±SD | 9.03 ±4.87 | 6.91 ±3.69 | 7.15 ±3.89 | ||
M (min:max) | 8.64 (3.3:23.81) | 6.2 (0.9:19.2) | 6.3 (0.9:23.81) | ||
M (IQR) | 8.64 (5.6-12.4) | 6.2 (4.2-8.52) | 6.3 (4.2-8.99) | ||
Gμ ±SD | 7.91 ±1.7 | 6.03 ±1.71 | 6.22 ±1.71 | ||
PMN (*1000/uL) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.009 |
μ ±SD | 7.88 ±4.81 | 5.43 ±3.54 | 5.71 ±3.78 | ||
M (min:max) | 7.04 (2.47:22.43) | 4.49 (0.29:17.56) | 4.62 (0.29:22.43) | ||
M (IQR) | 7.04 (3.66-10.93) | 4.49 (2.86-6.76) | 4.62 (2.88-7.4) | ||
Gμ ±SD | 6.59 ±1.86 | 4.40 ±1.96 | 4.61 ±1.97 | ||
Lymphocytes (*1000/uL) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.006 |
μ ±SD | 0.723 ±0.537 | 0.987 ±0.706 | 0.957 ±0.693 | ||
M (min:max) | 0.6 (0.21:2.84) | 0.85 (0.17:7.18) | 0.83 (0.17:7.18) | ||
M (IQR) | 0.6 (0.42-0.84) | 0.85 (0.57-1.2) | 0.83 (0.55-1.14) | ||
Gμ ±SD | 0.606 ±1.78 | 0.824 ±1.83 | 0.796 ±1.84 | ||
Platelets (*1000/uL) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.609 |
μ ±SD | 207.60 ±91.9 | 193.72 ±84.5 | 195.29 ±85.3 | ||
M (min:max) | 184 (75:414) | 184 (5:630) | 184 (5:630) | ||
M (IQR) | 184 (128-254) | 184 (135.75-233.5) | 184 (135-238) | ||
Gμ ±SD | 189.26 ±1.55 | 173.59 ±1.72 | 175.29 ±1.7 | ||
Hemoglobin (g/dL) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.230 |
μ ±SD | 12.52 ±2.19 | 13.14 ±1.87 | 13.07 ±1.91 | ||
M (min:max) | 13.3 (7.7:15.7) | 13.4 (5.8:16.9) | 13.4 (5.8:16.9) | ||
M (IQR) | 13.3 (11.5-14.1) | 13.4 (12-14.5) | 13.4 (11.9-14.4) | ||
Gμ ±SD | 12.31 ±1.21 | 13.00 ±1.17 | 12.92 ±1.18 | ||
Fibrinogen (mg/dL) | N (%) | 17 (68.0%) | 167 (85.2%) | 184 (83.3%) | MW: p=0.949 |
μ ±SD | 538.18 ±201.3 | 524.75 ±166.9 | 525.99 ±169.8 | ||
M (min:max) | 449.88 (255.87:882) | 505.21 (142.83:947.04) | 504.02 (142.83:947.04) | ||
M (IQR) | 449.88 (390.97-742.4) | 505.21 (399.52-626.36) | 504.02 (396.78-631.11) | ||
Gμ ±SD | 503.17 ±1.46 | 497.20 ±1.4 | 497.75 ±1.41 | ||
D-dimer (mg/L) | N (%) | 23 (92.0%) | 178 (90.8%) | 201 (91.0%) | MW: p=0.015 |
μ ±SD | 6.60 ±17.9 | 2.14 ±7.46 | 2.65 ±9.29 | ||
M (min:max) | 1.08 (0.22:68.31) | 0.7 (0.19:80) | 0.72 (0.19:80) | ||
M (IQR) | 1.08 (0.78-1.63) | 0.7 (0.42-1.25) | 0.72 (0.43-1.39) | ||
Gμ ±SD | 1.41 ±4.0 | 0.813 ±2.78 | 0.866 ±2.94 | ||
CRP (mg/dL) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.023 |
μ ±SD | 13.86 ±8.24 | 10.36 ±8.71 | 10.76 ±8.71 | ||
M (min:max) | 11.27 (1:27.32) | 8.09 (0.06:54.35) | 8.78 (0.06:54.35) | ||
M (IQR) | 11.27 (8.32-21.96) | 8.09 (3.79-14.7) | 8.78 (4.17-15.2) | ||
Gμ ±SD | 10.57 ±2.42 | 6.49 ±3.29 | 6.86 ±3.22 | ||
CRP >7.5 mg/dL | 20 (80.0%) | 109 (55.6%) | 129 (58.4%) | OR=3.19 [1.15, 8.85] (p=0.030) | |
PCT (ng/mL) | N (%) | 9 (36.0%) | 37 (18.9%) | 46 (20.8%) | MW: p=0.814 |
μ ±SD | 0.603 ±0.936 | 0.812 ±2.63 | 0.772 ±2.39 | ||
M (min:max) | 0.19 (0.05:2.68) | 0.16 (0.05:16.08) | 0.16 (0.05:16.08) | ||
M (IQR) | 0.19 (0.12-0.24) | 0.16 (0.08-0.41) | 0.16 (0.08-0.41) | ||
Gμ ±SD | 0.247 ±3.75 | 0.232 ±3.61 | 0.235 ±3.58 | ||
Ferritin (ng/mL) | N (%) | 25 (100%) | 185 (94.4%) | 210 (95.0%) | MW: p=0.031 |
μ ±SD | 1203.05 ±1107.2 | 701.77 ±678.6 | 761.44 ±756.8 | ||
M (min:max) | 634.9 (71:4175) | 511.8 (40.5:4815) | 526.85 (40.5:4815) | ||
M (IQR) | 634.9 (444.9-2148) | 511.8 (253.2-915) | 526.85 (274.75-939.45) | ||
Gμ ±SD | 766.41 ±2.85 | 472.15 ±2.57 | 500.18 ±2.63 | ||
ALT (U/L) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.403 |
μ ±SD | 312.68 ±1315.4 | 45.18 ±38.2 | 75.44 ±444.1 | ||
M (min:max) | 36 (7:6624) | 33 (6:257) | 34 (6:6624) | ||
M (IQR) | 36 (26-66) | 33 (21-56) | 34 (21-59) | ||
Gμ ±SD | 46.54 ±3.56 | 34.87 ±2.02 | 36.03 ±2.2 | ||
AST (U/L) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.190 |
μ ±SD | 557.00 ±2501.6 | 48.98 ±41.6 | 106.45 ±842.8 | ||
M (min:max) | 42 (9:12563) | 39 (9:368) | 39 (9:12563) | ||
M (IQR) | 42 (35-56) | 39 (27-54.25) | 39 (28-56) | ||
Gμ ±SD | 56.73 ±3.67 | 40.40 ±1.78 | 41.98 ±2.02 | ||
LDH (U/L) | N (%) | 22 (88.0%) | 192 (98.0%) | 214 (96.8%) | MW: p<0.001 |
μ ±SD | 464.73 ±152.2 | 356.69 ±145.3 | 367.79 ±149.3 | ||
M (min:max) | 433.5 (171:750) | 336 (145:1060) | 359 (145:1060) | ||
M (IQR) | 433.5 (381.5-571.5) | 336 (244.25-433) | 359 (248.25-452.5) | ||
Gμ ±SD | 437.94 ±1.45 | 331.33 ±1.46 | 340.97 ±1.47 | ||
μ ±SD = Mean ± standard deviation; M (min:max) = Median (min:max); MW = Mann-Whitney Test; OR = odds-ratio [95% CI] and p value from Fisher test); * custom text |
Day 0
Variable | Details | yes | no | Total | Statistics |
Deceased | 25 (11.3%) | 196 (88.7%) | 221 | ||
IL6 (pg/mL) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p<0.001 |
μ ±SD | 223.91 ±170.5 | 120.95 ±110.4 | 132.59 ±122.7 | ||
M (min:max) | 146.48 (56.46:747.68) | 88.48 (3.64:747.62) | 94.42 (3.64:747.68) | ||
M (IQR) | 146.48 (106.8-325.77) | 88.48 (53.42-152.35) | 94.42 (58.42-159.42) | ||
Gμ ±SD | 175.35 ±2.02 | 86.55 ±2.39 | 93.75 ±2.41 | ||
IL6 >150 pg/mL | 12 (48.0%) | 51 (26.0%) | 63 (28.5%) | OR=2.62 [1.13, 6.12] (p=0.033) | |
WBC (*1000/uL) | N (%) | 23 (92.0%) | 174 (88.8%) | 197 (89.1%) | MW: p=0.019 |
μ ±SD | 10.85 ±4.78 | 8.32 ±3.91 | 8.62 ±4.09 | ||
M (min:max) | 11.55 (4.1:18.71) | 7.5 (1:22.7) | 7.6 (1:22.7) | ||
M (IQR) | 11.55 (6.7-14.82) | 7.5 (5.62-10.84) | 7.6 (5.7-11.1) | ||
Gμ ±SD | 9.77 ±1.62 | 7.43 ±1.65 | 7.67 ±1.65 | ||
PMN (*1000/uL) | N (%) | 23 (92.0%) | 174 (88.8%) | 197 (89.1%) | MW: p=0.003 |
μ ±SD | 9.73 ±4.67 | 6.78 ±3.57 | 7.12 ±3.82 | ||
M (min:max) | 10.95 (2.57:17.91) | 6.35 (0.71:19.94) | 6.44 (0.71:19.94) | ||
M (IQR) | 10.95 (5.96-12.91) | 6.35 (4.15-9.02) | 6.44 (4.35-9.28) | ||
Gμ ±SD | 8.50 ±1.76 | 5.83 ±1.8 | 6.09 ±1.82 | ||
Lymphocytes (*1000/uL) | N (%) | 23 (92.0%) | 174 (88.8%) | 197 (89.1%) | MW: p<0.001 |
μ ±SD | 0.641 ±0.431 | 0.993 ±0.863 | 0.952 ±0.832 | ||
M (min:max) | 0.51 (0.24:2.32) | 0.86 (0.15:8.72) | 0.83 (0.15:8.72) | ||
M (IQR) | 0.51 (0.43-0.84) | 0.86 (0.56-1.19) | 0.83 (0.51-1.15) | ||
Gμ ±SD | 0.557 ±1.67 | 0.822 ±1.81 | 0.785 ±1.82 | ||
Platelets (*1000/uL) | N (%) | 23 (92.0%) | 174 (88.8%) | 197 (89.1%) | MW: p=0.772 |
μ ±SD | 244.65 ±126.9 | 220.34 ±93.4 | 223.18 ±97.8 | ||
M (min:max) | 210 (123:594) | 204 (2:596) | 204 (2:596) | ||
M (IQR) | 210 (140-317.5) | 204 (161-276.5) | 204 (159-282) | ||
Gμ ±SD | 218.41 ±1.61 | 198.37 ±1.73 | 200.61 ±1.71 | ||
Hemoglobin (g/dL) | N (%) | 23 (92.0%) | 174 (88.8%) | 197 (89.1%) | MW: p=0.092 |
μ ±SD | 11.90 ±2.28 | 12.75 ±1.73 | 12.65 ±1.81 | ||
M (min:max) | 12.4 (7.7:15.8) | 12.95 (6.3:15.8) | 12.9 (6.3:15.8) | ||
M (IQR) | 12.4 (10.25-13.5) | 12.95 (11.62-13.9) | 12.9 (11.5-13.9) | ||
Gμ ±SD | 11.67 ±1.22 | 12.63 ±1.16 | 12.51 ±1.17 | ||
Fibrinogen (mg/dL) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.383 |
μ ±SD | 582.33 ±195.3 | 541.94 ±163.9 | 546.51 ±167.7 | ||
M (min:max) | 542 (211.2:1101.74) | 534.23 (142.83:947.04) | 534.23 (142.83:1101.74) | ||
M (IQR) | 542 (449.88-712) | 534.23 (418.14-636.12) | 534.23 (422.3-645) | ||
Gμ ±SD | 551.06 ±1.41 | 516.09 ±1.38 | 519.93 ±1.39 | ||
D-dimer (mg/L) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.002 |
μ ±SD | 11.23 ±22.7 | 2.54 ±7.35 | 3.53 ±10.6 | ||
M (min:max) | 1.22 (0.37:80) | 0.72 (0.19:80) | 0.82 (0.19:80) | ||
M (IQR) | 1.22 (0.86-3.73) | 0.72 (0.43-1.51) | 0.82 (0.46-1.68) | ||
Gμ ±SD | 2.36 ±5.14 | 0.938 ±3.06 | 1.04 ±3.39 | ||
CRP (mg/dL) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.258 |
μ ±SD | 12.92 ±9.79 | 10.68 ±8.39 | 10.93 ±8.56 | ||
M (min:max) | 11.11 (1.16:40.56) | 8.9 (0.46:54.35) | 9.12 (0.46:54.35) | ||
M (IQR) | 11.11 (5.78-14.57) | 8.9 (4.82-14.54) | 9.12 (4.85-14.57) | ||
Gμ ±SD | 9.69 ±2.28 | 7.74 ±2.41 | 7.94 ±2.4 | ||
CRP >7.5 mg/dL | 16 (64.0%) | 112 (57.1%) | 128 (57.9%) | OR=1.33 [0.56, 3.16] (p=0.668) | |
PCT (ng/mL) | N (%) | 10 (40.0%) | 62 (31.6%) | 72 (32.6%) | MW: p=0.105 |
μ ±SD | 1.02 ±1.52 | 0.485 ±2.04 | 0.559 ±1.97 | ||
M (min:max) | 0.24 (0.05:4.65) | 0.14 (0.05:16.08) | 0.14 (0.05:16.08) | ||
M (IQR) | 0.24 (0.11-1.13) | 0.14 (0.08-0.22) | 0.14 (0.08-0.26) | ||
Gμ ±SD | 0.363 ±4.65 | 0.158 ±2.81 | 0.177 ±3.12 | ||
Ferritin (ng/mL) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.075 |
μ ±SD | 1052.98 ±949.2 | 713.63 ±596.4 | 752.02 ±652.0 | ||
M (min:max) | 761 (101.4:4214) | 575.65 (48.9:3718) | 584 (48.9:4214) | ||
M (IQR) | 761 (444.1-1448) | 575.65 (281.88-894.72) | 584 (303.7-938.5) | ||
Gμ ±SD | 738.96 ±2.43 | 517.80 ±2.33 | 539.06 ±2.35 | ||
ALT (U/L) | N (%) | 22 (88.0%) | 162 (82.7%) | 184 (83.3%) | MW: p=0.489 |
μ ±SD | 151.59 ±452.2 | 53.79 ±45.3 | 65.48 ±162.1 | ||
M (min:max) | 39 (7:2168) | 42 (6:290) | 42 (6:2168) | ||
M (IQR) | 39 (28-88.5) | 42 (25-65.5) | 42 (25-66.25) | ||
Gμ ±SD | 51.15 ±3.06 | 40.83 ±2.09 | 41.95 ±2.21 | ||
AST (U/L) | N (%) | 22 (88.0%) | 163 (83.2%) | 185 (83.7%) | MW: p=0.231 |
μ ±SD | 99.05 ±232.8 | 48.81 ±32.5 | 54.78 ±85.9 | ||
M (min:max) | 43 (9:1136) | 40 (9:215) | 41 (9:1136) | ||
M (IQR) | 43 (35.75-70.75) | 40 (26.5-59.5) | 41 (27-61) | ||
Gμ ±SD | 50.57 ±2.43 | 40.83 ±1.81 | 41.88 ±1.89 | ||
LDH (U/L) | N (%) | 24 (96.0%) | 195 (99.5%) | 219 (99.1%) | MW: p<0.001 |
μ ±SD | 544.88 ±266.6 | 390.23 ±157.2 | 407.18 ±178.4 | ||
M (min:max) | 488 (171:1365) | 362 (145:983) | 379 (145:1365) | ||
M (IQR) | 488 (386.75-588.75) | 362 (277.5-479.5) | 379 (289.5-490) | ||
Gμ ±SD | 496.97 ±1.53 | 362.38 ±1.47 | 375.14 ±1.49 | ||
μ ±SD = Mean ± standard deviation; M (min:max) = Median (min:max); MW = Mann-Whitney Test; OR = odds-ratio [95% CI] and p value from Fisher test); * custom text |
Day 1
Variable | Details | yes | no | Total | Statistics |
Deceased | 25 (11.3%) | 196 (88.7%) | 221 | ||
IL6 (pg/mL) | N (%) | 8 (32.0%) | 63 (32.1%) | 71 (32.1%) | MW: p=0.116 |
μ ±SD | 579.05 ±394.8 | 373.54 ±350.3 | 396.70 ±358.5 | ||
M (min:max) | 536.98 (123.08:1264.87) | 252.78 (1.2:1414.34) | 265.39 (1.2:1414.34) | ||
M (IQR) | 536.98 (286.08-796.87) | 252.78 (129.02-559.95) | 265.39 (135.52-582.1) | ||
Gμ ±SD | 445.33 ±2.32 | 214.34 ±3.61 | 232.75 ±3.53 | ||
IL6 >150 pg/mL | 6 (75.0%) | 43 (68.3%) | 49 (69.0%) | OR=1.40 [0.26, 7.53] (p>0.999) | |
WBC (*1000/uL) | N (%) | 22 (88.0%) | 131 (66.8%) | 153 (69.2%) | MW: p=0.005 |
μ ±SD | 9.41 ±4.51 | 6.66 ±3.73 | 7.06 ±3.96 | ||
M (min:max) | 8.08 (4.1:19.65) | 6.38 (1:22.37) | 6.68 (1:22.37) | ||
M (IQR) | 8.08 (6.71-11.08) | 6.38 (4.05-8.31) | 6.68 (4.3-8.7) | ||
Gμ ±SD | 8.49 ±1.59 | 5.71 ±1.79 | 6.05 ±1.79 | ||
PMN (*1000/uL) | N (%) | 22 (88.0%) | 133 (67.9%) | 155 (70.1%) | MW: p<0.001 |
μ ±SD | 8.47 ±4.32 | 5.32 ±3.54 | 5.77 ±3.8 | ||
M (min:max) | 7.3 (3.21:17.9) | 4.81 (0.6:21.45) | 5.11 (0.6:21.45) | ||
M (IQR) | 7.3 (5.22-9.87) | 4.81 (2.66-6.99) | 5.11 (3.17-7.43) | ||
Gμ ±SD | 7.53 ±1.64 | 4.29 ±2.0 | 4.65 ±2.01 | ||
Lymphocytes (*1000/uL) | N (%) | 22 (88.0%) | 133 (67.9%) | 155 (70.1%) | MW: p=0.021 |
μ ±SD | 0.708 ±0.695 | 0.888 ±0.64 | 0.862 ±0.649 | ||
M (min:max) | 0.52 (0.17:3.55) | 0.72 (0.18:5.38) | 0.7 (0.17:5.38) | ||
M (IQR) | 0.52 (0.38-0.77) | 0.72 (0.48-1.09) | 0.7 (0.47-1.03) | ||
Gμ ±SD | 0.56 ±1.88 | 0.738 ±1.82 | 0.71 ±1.84 | ||
Platelets (*1000/uL) | N (%) | 22 (88.0%) | 133 (67.9%) | 155 (70.1%) | MW: p=0.772 |
μ ±SD | 266.09 ±133.0 | 247.71 ±101.1 | 250.32 ±105.9 | ||
M (min:max) | 234 (67:608) | 238 (4:563) | 238 (4:608) | ||
M (IQR) | 234 (165-349) | 238 (169-315) | 238 (169-324) | ||
Gμ ±SD | 235.17 ±1.69 | 222.01 ±1.75 | 223.83 ±1.74 | ||
Hemoglobin (g/dL) | N (%) | 22 (88.0%) | 133 (67.9%) | 155 (70.1%) | MW: p=0.172 |
μ ±SD | 11.98 ±2.12 | 12.69 ±1.8 | 12.59 ±1.86 | ||
M (min:max) | 12.65 (7.3:15.1) | 12.8 (5.9:16.9) | 12.8 (5.9:16.9) | ||
M (IQR) | 12.65 (10.67-13.2) | 12.8 (11.4-14) | 12.8 (11.2-13.9) | ||
Gμ ±SD | 11.78 ±1.21 | 12.55 ±1.17 | 12.44 ±1.17 | ||
Fibrinogen (mg/dL) | N (%) | 11 (44.0%) | 77 (39.3%) | 88 (39.8%) | MW: p=0.752 |
μ ±SD | 570.86 ±99.7 | 562.49 ±140.6 | 563.54 ±135.7 | ||
M (min:max) | 586.67 (383.85:718) | 560.03 (197.66:923.43) | 564.5 (197.66:923.43) | ||
M (IQR) | 586.67 (517.34-639.69) | 560.03 (461-657.49) | 564.5 (461.1-657.49) | ||
Gμ ±SD | 562.41 ±1.2 | 544.16 ±1.31 | 546.41 ±1.29 | ||
D-dimer (mg/L) | N (%) | 16 (64.0%) | 127 (64.8%) | 143 (64.7%) | MW: p=0.003 |
μ ±SD | 13.46 ±23.7 | 4.38 ±10.9 | 5.39 ±13.2 | ||
M (min:max) | 2.72 (0.48:80) | 1.01 (0.19:80) | 1.11 (0.19:80) | ||
M (IQR) | 2.72 (1.7-10.14) | 1.01 (0.54-2.46) | 1.11 (0.58-3.12) | ||
Gμ ±SD | 4.13 ±4.62 | 1.38 ±3.68 | 1.56 ±3.93 | ||
CRP (mg/dL) | N (%) | 21 (84.0%) | 153 (78.1%) | 174 (78.7%) | MW: p=0.036 |
μ ±SD | 12.39 ±7.54 | 9.10 ±6.98 | 9.50 ±7.11 | ||
M (min:max) | 10.79 (3.35:30.6) | 7.62 (0.66:47.74) | 7.96 (0.66:47.74) | ||
M (IQR) | 10.79 (6.82-14.9) | 7.62 (4.01-12.96) | 7.96 (4.22-13.61) | ||
Gμ ±SD | 10.35 ±1.88 | 6.68 ±2.37 | 7.04 ±2.33 | ||
CRP >7.5 mg/dL | 14 (66.7%) | 78 (51.0%) | 92 (52.9%) | OR=1.92 [0.74, 5.03] (p=0.244) | |
PCT (ng/mL) | N (%) | 3 (12.0%) | 19 (9.7%) | 22 (10.0%) | MW: p=0.068 |
μ ±SD | 0.67 ±0.0954 | 0.567 ±1.55 | 0.581 ±1.43 | ||
M (min:max) | 0.68 (0.57:0.76) | 0.1 (0.05:6.87) | 0.12 (0.05:6.87) | ||
M (IQR) | 0.68 (0.62-0.72) | 0.1 (0.06-0.31) | 0.12 (0.07-0.55) | ||
Gμ ±SD | 0.666 ±1.16 | 0.165 ±3.62 | 0.199 ±3.63 | ||
Ferritin (ng/mL) | N (%) | 14 (56.0%) | 131 (66.8%) | 145 (65.6%) | MW: p=0.289 |
μ ±SD | 1053.43 ±609.9 | 949.49 ±766.9 | 959.53 ±752.0 | ||
M (min:max) | 970.9 (198.8:2128) | 757.9 (116.6:3369) | 765.9 (116.6:3369) | ||
M (IQR) | 970.9 (622.75-1452.17) | 757.9 (401.6-1190) | 765.9 (420.1-1198.5) | ||
Gμ ±SD | 870.62 ±2.0 | 707.75 ±2.2 | 722.04 ±2.18 | ||
ALT (U/L) | N (%) | 19 (76.0%) | 111 (56.6%) | 130 (58.8%) | MW: p=0.412 |
μ ±SD | 98.74 ±224.0 | 60.86 ±43.5 | 66.39 ±93.8 | ||
M (min:max) | 40 (18:1014) | 54 (6:248) | 52 (6:1014) | ||
M (IQR) | 40 (23-76.5) | 54 (27-78) | 52 (26-78.5) | ||
Gμ ±SD | 46.28 ±2.65 | 47.30 ±2.11 | 47.15 ±2.18 | ||
AST (U/L) | N (%) | 19 (76.0%) | 112 (57.1%) | 131 (59.3%) | MW: p=0.626 |
μ ±SD | 61.37 ±60.8 | 51.53 ±32.5 | 52.95 ±37.8 | ||
M (min:max) | 47 (16:298) | 43 (10:207) | 44 (10:298) | ||
M (IQR) | 47 (34.5-66.5) | 43 (29-66.75) | 44 (31-67.5) | ||
Gμ ±SD | 48.29 ±1.9 | 43.35 ±1.81 | 44.03 ±1.82 | ||
LDH (U/L) | N (%) | 17 (68.0%) | 98 (50.0%) | 115 (52.0%) | MW: p=0.002 |
μ ±SD | 597.76 ±213.9 | 435.52 ±158.9 | 459.50 ±176.8 | ||
M (min:max) | 551 (267:1019) | 402 (198:954) | 425 (198:1019) | ||
M (IQR) | 551 (432-777) | 402 (308.25-534.5) | 425 (319.5-552.5) | ||
Gμ ±SD | 562.49 ±1.44 | 409.51 ±1.42 | 429.18 ±1.44 | ||
μ ±SD = Mean ± standard deviation; M (min:max) = Median (min:max); MW = Mann-Whitney Test; OR = odds-ratio [95% CI] and p value from Fisher test); * custom text |
Day 3
Variable | Details | yes | no | Total | Statistics |
Deceased | 25 (11.3%) | 196 (88.7%) | 221 | ||
IL6 (pg/mL) | N (%) | 7 (28.0%) | 69 (35.2%) | 76 (34.4%) | MW: p=0.011 |
μ ±SD | 779.52 ±487.9 | 354.80 ±382.6 | 393.92 ±408.7 | ||
M (min:max) | 934.82 (244.49:1590.64) | 164.68 (11.82:1497.95) | 219.89 (11.82:1590.64) | ||
M (IQR) | 934.82 (352.84-990.5) | 164.68 (86.73-570.3) | 219.89 (93.22-594.97) | ||
Gμ ±SD | 638.37 ±2.05 | 184.60 ±3.56 | 206.95 ±3.59 | ||
IL6 >150 pg/mL | 7 (100%) | 40 (58.0%) | 47 (61.8%) | OR=10.93 [0.60, 198.92] (p=0.040) | |
WBC (*1000/uL) | N (%) | 19 (76.0%) | 150 (76.5%) | 169 (76.5%) | MW: p=0.009 |
μ ±SD | 12.40 ±7.63 | 7.67 ±4.22 | 8.21 ±4.93 | ||
M (min:max) | 8.8 (3.51:27.75) | 7.03 (1.1:27.4) | 7.5 (1.1:27.75) | ||
M (IQR) | 8.8 (7.2-16.05) | 7.03 (4.53-9.75) | 7.5 (4.8-10) | ||
Gμ ±SD | 10.44 ±1.82 | 6.62 ±1.76 | 6.96 ±1.8 | ||
PMN (*1000/uL) | N (%) | 19 (76.0%) | 150 (76.5%) | 169 (76.5%) | MW: p<0.001 |
μ ±SD | 11.22 ±7.3 | 5.99 ±3.97 | 6.57 ±4.73 | ||
M (min:max) | 7.8 (2.53:26.42) | 5.23 (0.63:25.32) | 5.63 (0.63:26.42) | ||
M (IQR) | 7.8 (6.06-14.46) | 5.23 (3.1-7.85) | 5.63 (3.28-8.24) | ||
Gμ ±SD | 9.23 ±1.91 | 4.83 ±1.99 | 5.19 ±2.04 | ||
Lymphocytes (*1000/uL) | N (%) | 19 (76.0%) | 150 (76.5%) | 169 (76.5%) | MW: p=0.009 |
μ ±SD | 0.919 ±1.17 | 1.12 ±0.822 | 1.10 ±0.866 | ||
M (min:max) | 0.63 (0.17:5.35) | 0.88 (0.19:7.18) | 0.85 (0.17:7.18) | ||
M (IQR) | 0.63 (0.39-0.79) | 0.88 (0.6-1.37) | 0.85 (0.58-1.35) | ||
Gμ ±SD | 0.637 ±2.17 | 0.932 ±1.81 | 0.893 ±1.87 | ||
Platelets (*1000/uL) | N (%) | 19 (76.0%) | 150 (76.5%) | 169 (76.5%) | MW: p=0.227 |
μ ±SD | 259.95 ±132.4 | 279.25 ±102.8 | 277.08 ±106.3 | ||
M (min:max) | 235 (85:647) | 275 (4:539) | 272 (4:647) | ||
M (IQR) | 235 (169.5-304) | 275 (209.5-346.25) | 272 (203-344) | ||
Gμ ±SD | 231.67 ±1.65 | 253.85 ±1.7 | 251.25 ±1.7 | ||
Hemoglobin (g/dL) | N (%) | 19 (76.0%) | 150 (76.5%) | 169 (76.5%) | MW: p=0.669 |
μ ±SD | 12.42 ±2.27 | 12.71 ±1.78 | 12.67 ±1.83 | ||
M (min:max) | 12.3 (8.7:16) | 12.95 (6.7:17.2) | 12.9 (6.7:17.2) | ||
M (IQR) | 12.3 (10.7-14.05) | 12.95 (11.65-13.9) | 12.9 (11.4-13.9) | ||
Gμ ±SD | 12.22 ±1.21 | 12.57 ±1.16 | 12.53 ±1.17 | ||
Fibrinogen (mg/dL) | N (%) | 9 (36.0%) | 92 (46.9%) | 101 (45.7%) | MW: p=0.825 |
μ ±SD | 415.61 ±102.6 | 407.18 ±113.0 | 407.93 ±111.6 | ||
M (min:max) | 410.24 (271:559.72) | 393.86 (158.21:784.56) | 395.62 (158.21:784.56) | ||
M (IQR) | 410.24 (364.6-517.34) | 393.86 (334.31-466.97) | 395.62 (335.35-466.97) | ||
Gμ ±SD | 404.16 ±1.29 | 391.62 ±1.33 | 392.73 ±1.33 | ||
D-dimer (mg/L) | N (%) | 16 (64.0%) | 139 (70.9%) | 155 (70.1%) | MW: p=0.001 |
μ ±SD | 9.62 ±12.6 | 3.64 ±8.79 | 4.26 ±9.38 | ||
M (min:max) | 3.79 (0.38:40.42) | 0.94 (0.19:71.96) | 1.03 (0.19:71.96) | ||
M (IQR) | 3.79 (1.63-11.68) | 0.94 (0.57-2.13) | 1.03 (0.58-2.57) | ||
Gμ ±SD | 4.11 ±4.07 | 1.30 ±3.36 | 1.46 ±3.59 | ||
CRP (mg/dL) | N (%) | 20 (80.0%) | 157 (80.1%) | 177 (80.1%) | MW: p=0.057 |
μ ±SD | 4.81 ±4.55 | 2.60 ±2.01 | 2.85 ±2.51 | ||
M (min:max) | 3.09 (0.18:18.39) | 2.07 (0.11:11.37) | 2.1 (0.11:18.39) | ||
M (IQR) | 3.09 (1.49-7.35) | 2.07 (1.08-3.68) | 2.1 (1.09-3.97) | ||
Gμ ±SD | 2.78 ±3.49 | 1.84 ±2.54 | 1.93 ±2.65 | ||
CRP >7.5 mg/dL | 5 (25.0%) | 5 (3.2%) | 10 (5.6%) | OR=10.13 [2.63, 39.02] (p=0.002) | |
PCT (ng/mL) | N (%) | 3 (12.0%) | 11 (5.6%) | 14 (6.3%) | MW: p=0.184 |
μ ±SD | 1.44 ±1.69 | 0.122 ±0.0747 | 0.404 ±0.869 | ||
M (min:max) | 0.89 (0.09:3.33) | 0.1 (0.05:0.32) | 0.11 (0.05:3.33) | ||
M (IQR) | 0.89 (0.49-2.11) | 0.1 (0.08-0.14) | 0.11 (0.09-0.16) | ||
Gμ ±SD | 0.646 ±6.18 | 0.108 ±1.69 | 0.158 ±3.13 | ||
Ferritin (ng/mL) | N (%) | 16 (64.0%) | 133 (67.9%) | 149 (67.4%) | MW: p=0.372 |
μ ±SD | 1138.38 ±1373.9 | 787.95 ±634.1 | 825.58 ±749.5 | ||
M (min:max) | 716.45 (188.4:5943) | 676 (68.1:4669) | 682.9 (68.1:5943) | ||
M (IQR) | 716.45 (629.68-935.02) | 676 (352.6-1021.7) | 682.9 (355.7-1021.7) | ||
Gμ ±SD | 795.50 ±2.21 | 590.06 ±2.23 | 609.30 ±2.23 | ||
ALT (U/L) | N (%) | 16 (64.0%) | 126 (64.3%) | 142 (64.3%) | MW: p=0.108 |
μ ±SD | 58.62 ±46.6 | 84.36 ±73.3 | 81.46 ±71.2 | ||
M (min:max) | 38.5 (14:171) | 61 (7:418) | 59 (7:418) | ||
M (IQR) | 38.5 (24.75-80) | 61 (38.25-105) | 59 (36-101.75) | ||
Gμ ±SD | 44.63 ±2.13 | 62.35 ±2.18 | 60.04 ±2.19 | ||
AST (U/L) | N (%) | 16 (64.0%) | 124 (63.3%) | 140 (63.3%) | MW: p=0.578 |
μ ±SD | 58.00 ±32.2 | 54.49 ±32.7 | 54.89 ±32.5 | ||
M (min:max) | 51 (17:137) | 46 (10:191) | 46 (10:191) | ||
M (IQR) | 51 (35.5-76.25) | 46 (33-70) | 46 (33-70.5) | ||
Gμ ±SD | 50.42 ±1.74 | 46.11 ±1.8 | 46.59 ±1.79 | ||
LDH (U/L) | N (%) | 16 (64.0%) | 96 (49.0%) | 112 (50.7%) | MW: p<0.001 |
μ ±SD | 707.75 ±289.0 | 432.67 ±184.4 | 471.96 ±223.0 | ||
M (min:max) | 684.5 (314:1285) | 377 (175:974) | 417 (175:1285) | ||
M (IQR) | 684.5 (497.25-862.25) | 377 (292.75-538) | 417 (313-583) | ||
Gμ ±SD | 652.90 ±1.52 | 398.14 ±1.5 | 427.29 ±1.56 | ||
μ ±SD = Mean ± standard deviation; M (min:max) = Median (min:max); MW = Mann-Whitney Test; OR = odds-ratio [95% CI] and p value from Fisher test); * custom text |
Day 7
Variable | Details | yes | no | Total | Statistics |
Deceased | 25 (11.3%) | 196 (88.7%) | 221 | ||
IL6 (pg/mL) | N (%) | 8 (32.0%) | 67 (34.2%) | 75 (33.9%) | MW: p=0.147 |
μ ±SD | 385.83 ±423.2 | 237.30 ±349.0 | 253.14 ±357.4 | ||
M (min:max) | 260.75 (57.2:1318.2) | 104.11 (7.5:1633) | 112.21 (7.5:1633) | ||
M (IQR) | 260.75 (82.47-460.37) | 104.11 (60.01-229) | 112.21 (61.25-256.53) | ||
Gμ ±SD | 231.48 ±3.02 | 117.80 ±3.21 | 126.60 ±3.22 | ||
IL6 >150 pg/mL | 5 (62.5%) | 26 (38.8%) | 31 (41.3%) | OR=2.63 [0.58, 11.94] (p=0.263) | |
WBC (*1000/uL) | N (%) | 19 (76.0%) | 145 (74.0%) | 164 (74.2%) | MW: p<0.001 |
μ ±SD | 14.55 ±6.69 | 9.10 ±4.7 | 9.74 ±5.25 | ||
M (min:max) | 12.83 (4.97:27.44) | 8.81 (1.78:24.8) | 9.25 (1.78:27.44) | ||
M (IQR) | 12.83 (9.96-18.8) | 8.81 (5-11.53) | 9.25 (5.85-12.45) | ||
Gμ ±SD | 13.11 ±1.62 | 7.89 ±1.75 | 8.37 ±1.78 | ||
PMN (*1000/uL) | N (%) | 19 (76.0%) | 144 (73.5%) | 163 (73.8%) | MW: p<0.001 |
μ ±SD | 13.05 ±6.57 | 6.76 ±4.35 | 7.50 ±5.06 | ||
M (min:max) | 11.45 (3.74:24.71) | 6.29 (0.74:22.6) | 6.88 (0.74:24.71) | ||
M (IQR) | 11.45 (7.98-17.49) | 6.29 (3-9.29) | 6.88 (3.52-9.96) | ||
Gμ ±SD | 11.44 ±1.73 | 5.31 ±2.13 | 5.81 ±2.17 | ||
Lymphocytes (*1000/uL) | N (%) | 19 (76.0%) | 145 (74.0%) | 164 (74.2%) | MW: p<0.001 |
μ ±SD | 0.792 ±0.492 | 1.60 ±1.35 | 1.51 ±1.3 | ||
M (min:max) | 0.72 (0.2:1.97) | 1.24 (0.21:10.61) | 1.2 (0.2:10.61) | ||
M (IQR) | 0.72 (0.37-1.08) | 1.24 (0.82-1.86) | 1.2 (0.77-1.8) | ||
Gμ ±SD | 0.647 ±1.99 | 1.28 ±1.91 | 1.19 ±1.99 | ||
Platelets (*1000/uL) | N (%) | 19 (76.0%) | 145 (74.0%) | 164 (74.2%) | MW: p=0.002 |
μ ±SD | 200.74 ±103.7 | 275.65 ±98.7 | 266.97 ±101.8 | ||
M (min:max) | 186 (25:436) | 279 (3:502) | 268 (3:502) | ||
M (IQR) | 186 (138-237) | 279 (208-341) | 268 (197.75-330.5) | ||
Gμ ±SD | 170.77 ±1.93 | 250.16 ±1.74 | 239.33 ±1.78 | ||
Hemoglobin (g/dL) | N (%) | 19 (76.0%) | 145 (74.0%) | 164 (74.2%) | MW: p=0.026 |
μ ±SD | 11.97 ±1.97 | 12.98 ±1.63 | 12.86 ±1.7 | ||
M (min:max) | 11.8 (8.9:16.2) | 13 (7.9:15.9) | 13 (7.9:16.2) | ||
M (IQR) | 11.8 (10.3-13.15) | 13 (12-14.3) | 13 (11.8-14.1) | ||
Gμ ±SD | 11.81 ±1.18 | 12.87 ±1.14 | 12.75 ±1.15 | ||
Fibrinogen (mg/dL) | N (%) | 8 (32.0%) | 79 (40.3%) | 87 (39.4%) | MW: p=0.204 |
μ ±SD | 260.84 ±109.2 | 288.01 ±82.3 | 285.51 ±84.7 | ||
M (min:max) | 243.9 (134.24:491.81) | 275.19 (100.62:526.68) | 268.74 (100.62:526.68) | ||
M (IQR) | 243.9 (197.36-278.72) | 275.19 (232.75-339.88) | 268.74 (230.72-332.74) | ||
Gμ ±SD | 243.64 ±1.47 | 276.27 ±1.35 | 273.10 ±1.36 | ||
D-dimer (mg/L) | N (%) | 17 (68.0%) | 128 (65.3%) | 145 (65.6%) | MW: p<0.001 |
μ ±SD | 9.80 ±16.1 | 2.12 ±2.95 | 3.02 ±6.52 | ||
M (min:max) | 3.27 (0.3:60.22) | 1.02 (0.19:16.78) | 1.15 (0.19:60.22) | ||
M (IQR) | 3.27 (2.03-5.67) | 1.02 (0.51-2.16) | 1.15 (0.53-2.96) | ||
Gμ ±SD | 3.78 ±4.01 | 1.14 ±2.92 | 1.31 ±3.24 | ||
CRP (mg/dL) | N (%) | 17 (68.0%) | 129 (65.8%) | 146 (66.1%) | MW: p=0.037 |
μ ±SD | 2.23 ±3.16 | 0.482 ±0.472 | 0.686 ±1.27 | ||
M (min:max) | 0.74 (0.08:9.5) | 0.38 (0.04:3.89) | 0.39 (0.04:9.5) | ||
M (IQR) | 0.74 (0.32-1.59) | 0.38 (0.2-0.57) | 0.39 (0.2-0.63) | ||
Gμ ±SD | 0.807 ±4.59 | 0.347 ±2.3 | 0.383 ±2.64 | ||
CRP >7.5 mg/dL | 2 (11.8%) | 0 | 2 (1.4%) | OR=41.77 [1.92, 910.50] (p=0.013) | |
PCT (ng/mL) | N (%) | 5 (20.0%) | 6 (3.1%) | 11 (5.0%) | MW: p=0.029 |
μ ±SD | 1.09 ±1.7 | 0.06 ±0.0245 | 0.53 ±1.2 | ||
M (min:max) | 0.33 (0.05:4.09) | 0.05 (0.05:0.11) | 0.05 (0.05:4.09) | ||
M (IQR) | 0.33 (0.15-0.85) | 0.05 (0.05-0.05) | 0.05 (0.05-0.24) | ||
Gμ ±SD | 0.389 ±5.33 | 0.0581 ±1.37 | 0.138 ±4.34 | ||
Ferritin (ng/mL) | N (%) | 14 (56.0%) | 116 (59.2%) | 130 (58.8%) | MW: p=0.281 |
μ ±SD | 958.71 ±1184.3 | 618.06 ±435.4 | 654.74 ±567.1 | ||
M (min:max) | 719.9 (159.6:4894) | 536.8 (47.4:2432) | 547.5 (47.4:4894) | ||
M (IQR) | 719.9 (376.97-976.45) | 536.8 (275.4-795.95) | 547.5 (291.45-804.8) | ||
Gμ ±SD | 643.33 ±2.38 | 476.86 ±2.17 | 492.49 ±2.2 | ||
ALT (U/L) | N (%) | 25 (100%) | 196 (100%) | 221 (100%) | MW: p=0.020 |
μ ±SD | 56.44 ±31.6 | 90.93 ±87.4 | 87.03 ±83.7 | ||
M (min:max) | 54 (19:144) | 67.5 (13:852) | 65 (13:852) | ||
M (IQR) | 54 (29-70) | 67.5 (45-99.25) | 65 (44-94) | ||
Gμ ±SD | 48.50 ±1.77 | 69.56 ±2.01 | 66.78 ±2.0 | ||
AST (U/L) | N (%) | 25 (100%) | 195 (99.5%) | 220 (99.5%) | MW: p=0.652 |
μ ±SD | 48.76 ±19.3 | 49.34 ±27.8 | 49.27 ±26.9 | ||
M (min:max) | 49 (20:98) | 45 (8:168) | 45 (8:168) | ||
M (IQR) | 49 (37-60) | 45 (29-62.5) | 45 (29-62.25) | ||
Gμ ±SD | 45.06 ±1.52 | 42.38 ±1.76 | 42.68 ±1.73 | ||
LDH (U/L) | N (%) | 15 (60.0%) | 90 (45.9%) | 105 (47.5%) | MW: p<0.001 |
μ ±SD | 699.60 ±216.3 | 367.82 ±143.4 | 415.22 ±193.7 | ||
M (min:max) | 780 (431:1083) | 346 (141:839) | 358 (141:1083) | ||
M (IQR) | 780 (498-823.5) | 346 (268-421.25) | 358 (274-503) | ||
Gμ ±SD | 668.12 ±1.37 | 343.30 ±1.45 | 377.56 ±1.54 | ||
μ ±SD = Mean ± standard deviation; M (min:max) = Median (min:max); MW = Mann-Whitney Test; OR = odds-ratio [95% CI] and p value from Fisher test); * custom text |
Table 5: Univariate analysis of all variables by year (2021 vs 2020, full descriptive table).
Main
Variable | Details | 2021 | 2020 | Total | Statistics |
Year | 113 (51.1%) | 108 (48.9%) | 221 | ||
Age (years) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.292 |
μ ±SD | 62.75 ±12.2 | 65.22 ±13.9 | 63.96 ±13.1 | ||
M (min:max) | 65 (24:88) | 64.5 (32:93) | 65 (24:93) | ||
Sex | F | 53 (46.9%) | 42 (38.9%) | 95 (43.0%) | OR=1.39 [0.81, 2.37] (p=0.277) |
M | 60 (53.1%) | 66 (61.1%) | 126 (57.0%) | ||
Deceased | 11 (9.7%) | 14 (13.0%) | 25 (11.3%) | OR=0.72 [0.31, 1.67] (p=0.526) | |
Length of stay (days) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.647 |
μ ±SD | 13.65 ±8.04 | 14.44 ±9.03 | 14.04 ±8.53 | ||
M (min:max) | 12 (1:43) | 12 (1:55) | 12 (1:55) | ||
M (IQR) | 12 (9-17) | 12 (8-18) | 12 (8-17) | ||
Gμ ±SD | 11.37 ±1.93 | 12.05 ±1.89 | 11.70 ±1.91 | ||
Onset to hospitalization (days) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.934 |
μ ±SD | 7.52 ±3.63 | 7.57 ±4.86 | 7.55 ±4.26 | ||
M (min:max) | 7 (0:28) | 7 (0:35) | 7 (0:35) | ||
M (IQR) | 7 (5-9) | 7 (4-10.25) | 7 (5-10) | ||
Gμ ±SD | 5.58 ±4.46 | 5.05 ±4.91 | 5.31 ±4.67 | ||
Admission to TCZ (days) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.011 |
μ ±SD | 3.17 ±3.06 | 4.56 ±3.94 | 3.85 ±3.58 | ||
M (min:max) | 3 (0:16) | 4 (0:16) | 3 (0:16) | ||
M (IQR) | 3 (1-4) | 4 (1-7) | 3 (1-6) | ||
Gμ ±SD | 0.681 ±24.5 | 1.57 ±13.9 | 1.02 ±19.2 | ||
TCZ >3 days after admission | 42 (37.2%) | 55 (50.9%) | 97 (43.9%) | OR=0.57 [0.33, 0.97] (p=0.043) | |
Onset to TCZ (days) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.024 |
μ ±SD | 10.64 ±4.23 | 12.06 ±5.98 | 11.33 ±5.2 | ||
M (min:max) | 10 (3:30) | 12 (0:40) | 11 (0:40) | ||
M (IQR) | 10 (8-12) | 12 (8-15.25) | 11 (8-14) | ||
Gμ ±SD | 9.94 ±1.44 | 9.77 ±2.88 | 9.86 ±2.19 | ||
Lung damage (%) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.211 |
μ ±SD | 54.42 ±21.7 | 50.32 ±23.1 | 52.42 ±22.5 | ||
M (min:max) | 60 (5:90) | 50 (5:90) | 50 (5:90) | ||
M (IQR) | 60 (40-70) | 50 (30-70) | 50 (40-70) | ||
Gμ ±SD | 48.37 ±1.75 | 43.16 ±1.88 | 45.75 ±1.81 | ||
Lung damage >40% | 74 (65.5%) | 68 (63.0%) | 142 (64.3%) | OR=1.12 [0.64, 1.94] (p=0.779) | |
WHO CPS | ≥6 | 87 (77.0%) | 64 (59.3%) | 151 (68.3%) | OR=2.30 [1.28, 4.12] (p=0.006) |
<6 | 26 (23.0%) | 44 (40.7%) | 70 (31.7%) | ||
Fever | 84 (74.3%) | 85 (78.7%) | 169 (76.5%) | OR=0.78 [0.42, 1.46] (p=0.526) | |
Cough | 98 (86.7%) | 73 (67.6%) | 171 (77.4%) | OR=3.13 [1.59, 6.16] (p<0.001) | |
Dyspnea | 69 (61.1%) | 57 (52.8%) | 126 (57.0%) | OR=1.40 [0.82, 2.39] (p=0.224) | |
Diarrhea | 14 (12.5%) | 12 (11.4%) | 26 (12.0%) | OR=1.11 [0.49, 2.52] (p=0.837) | |
Infections | 0 | 0 | 0 | OR=0.92 [0.02, 46.58] (p>0.999) | |
Sepsis/Pneumonia | 3 (2.7%) | 8 (7.4%) | 11 (5.0%) | OR=0.34 [0.09, 1.32] (p=0.129) | |
ICU admission | 25 (22.1%) | 40 (37.0%) | 65 (29.4%) | OR=0.48 [0.27, 0.87] (p=0.018) | |
Diabetes mellitus I | 0 | 0 | 0 | OR=0.96 [0.02, 48.60] (p>0.999) | |
Diabetes mellitus II | 37 (32.7%) | 39 (36.1%) | 76 (34.4%) | OR=0.86 [0.49, 1.50] (p=0.671) | |
Cardiovascular comorbidities | yes | 78 (69.0%) | 81 (75.0%) | 159 (71.9%) | OR=0.74 [0.41, 1.34] (p=0.370) |
N (%) | 113 (100%) | 108 (100%) | 221 (100%) | ||
μ ±SD | 1.42 ±1.45 | 1.62 ±1.48 | 1.52 ±1.46 | ||
M (min:max) | 1 (0:6) | 1 (0:6) | 1 (0:6) | ||
M (IQR) | 1 (0-2) | 1 (0.75-2.25) | 1 (0-2) | ||
Gμ ±SD | 0.171 ±32.9 | 0.278 ±27.2 | 0.217 ±30.1 | ||
Cardiovascular comorbidities (>2) | 21 (18.6%) | 27 (25.0%) | 48 (21.7%) | OR=0.68 [0.36, 1.30] (p=0.258) | |
High blood pressure | 74 (65.5%) | 77 (71.3%) | 151 (68.3%) | OR=0.76 [0.43, 1.35] (p=0.387) | |
Atrial fibrillation | 9 (8.0%) | 10 (9.3%) | 19 (8.6%) | OR=0.85 [0.33, 2.18] (p=0.813) | |
Arrhythmia | 5 (4.4%) | 6 (5.6%) | 11 (5.0%) | OR=0.79 [0.23, 2.66] (p=0.764) | |
Pulmonary embolism | 7 (6.2%) | 7 (6.5%) | 14 (6.4%) | OR=0.94 [0.32, 2.79] (p>0.999) | |
Peripheral artery disease | 1 (0.9%) | 5 (4.7%) | 6 (2.7%) | OR=0.18 [0.02, 1.59] (p=0.111) | |
Aortic aneurysm | 0 | 1 (0.9%) | 1 (0.5%) | OR=0.31 [0.01, 7.76] (p=0.486) | |
Coronary heart disease | 26 (23.0%) | 32 (29.6%) | 58 (26.2%) | OR=0.71 [0.39, 1.30] (p=0.287) | |
Valvulopathies | 13 (11.5%) | 9 (8.4%) | 22 (10.0%) | OR=1.42 [0.58, 3.46] (p=0.505) | |
Congestive Heart Failure | 12 (10.6%) | 12 (11.2%) | 24 (10.9%) | OR=0.94 [0.40, 2.20] (p>0.999) | |
Chronic venous insufficiency | 8 (7.1%) | 8 (7.4%) | 16 (7.2%) | OR=0.95 [0.34, 2.63] (p>0.999) | |
Stroke history | 6 (5.3%) | 8 (7.5%) | 14 (6.4%) | OR=0.69 [0.23, 2.07] (p=0.587) | |
Chronic kidney disease | 6 (5.3%) | 7 (6.5%) | 13 (5.9%) | OR=0.81 [0.26, 2.49] (p=0.780) | |
HD | 0 | 2 (1.9%) | 2 (0.9%) | OR=0.19 [0.01, 3.95] (p=0.238) | |
Chronic obstructive pulmonary disease | 7 (6.2%) | 9 (8.3%) | 16 (7.2%) | OR=0.73 [0.26, 2.02] (p=0.609) | |
Asthma | 7 (6.2%) | 1 (0.9%) | 8 (3.6%) | OR=7.07 [0.85, 58.42] (p=0.066) | |
Cancer | 13 (11.5%) | 16 (14.8%) | 29 (13.1%) | OR=0.75 [0.34, 1.64] (p=0.551) | |
Obesity | 60 (53.1%) | 43 (39.8%) | 103 (46.6%) | OR=1.71 [1.00, 2.92] (p=0.059) | |
Overweight | 23 (20.4%) | 24 (22.2%) | 47 (21.3%) | OR=0.89 [0.47, 1.70] (p=0.745) | |
Dexamethasone | 111 (98.2%) | 103 (95.4%) | 214 (96.8%) | OR=2.69 [0.51, 14.19] (p=0.272) | |
Anakinra | 20 (17.7%) | 12 (11.1%) | 32 (14.5%) | OR=1.72 [0.80, 3.72] (p=0.184) | |
Antibiotics | 112 (99.1%) | 106 (98.1%) | 218 (98.6%) | OR=2.11 [0.19, 23.65] (p=0.615) | |
Remdesivir | 76 (67.3%) | 40 (37.0%) | 116 (52.5%) | OR=3.49 [2.01, 6.08] (p<0.001) | |
Hydroxychloroquine | 38 (33.6%) | 93 (86.1%) | 131 (59.3%) | OR=0.08 [0.04, 0.16] (p<0.001) | |
Favipiravir | 85 (75.2%) | 13 (12.0%) | 98 (44.3%) | OR=22.18 [10.80, 45.57] (p<0.001) | |
μ ±SD = Mean ± standard deviation; M (min:max) = Median (min:max); MW = Mann-Whitney Test; OR = odds-ratio [95% CI] and p value from Fisher test); * custom text |
Admission
Variable | Details | 2021 | 2020 | Total | Statistics |
Year | 113 (51.1%) | 108 (48.9%) | 221 | ||
IL6 (pg/mL) | N (%) | 104 (92.0%) | 86 (79.6%) | 190 (86.0%) | MW: p=0.273 |
μ ±SD | 77.61 ±75.8 | 77.13 ±91.7 | 77.40 ±83.1 | ||
M (min:max) | 52.74 (1.33:514.67) | 46.89 (2.13:459.18) | 50.25 (1.33:514.67) | ||
M (IQR) | 52.74 (23.94-108.13) | 46.89 (16.3-97.19) | 50.25 (19.29-102.48) | ||
Gμ ±SD | 48.56 ±2.95 | 40.52 ±3.41 | 44.74 ±3.16 | ||
IL6 >150 pg/mL | 14 (13.5%) | 13 (15.1%) | 27 (14.2%) | OR=0.87 [0.39, 1.97] (p=0.836) | |
WBC (*1000/uL) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.003 |
μ ±SD | 6.49 ±3.61 | 7.84 ±4.06 | 7.15 ±3.89 | ||
M (min:max) | 5.6 (1.7:19.2) | 6.85 (0.9:23.81) | 6.3 (0.9:23.81) | ||
M (IQR) | 5.6 (4-7.8) | 6.85 (4.79-10) | 6.3 (4.2-8.99) | ||
Gμ ±SD | 5.67 ±1.67 | 6.84 ±1.73 | 6.22 ±1.71 | ||
PMN (*1000/uL) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.034 |
μ ±SD | 5.16 ±3.42 | 6.27 ±4.06 | 5.71 ±3.78 | ||
M (min:max) | 4.35 (0.71:17.56) | 5.55 (0.29:22.43) | 4.62 (0.29:22.43) | ||
M (IQR) | 4.35 (2.78-6.44) | 5.55 (3.17-8.37) | 4.62 (2.88-7.4) | ||
Gμ ±SD | 4.24 ±1.89 | 5.03 ±2.04 | 4.61 ±1.97 | ||
Lymphocytes (*1000/uL) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.064 |
μ ±SD | 0.86 ±0.493 | 1.06 ±0.845 | 0.957 ±0.693 | ||
M (min:max) | 0.77 (0.18:2.84) | 0.92 (0.17:7.18) | 0.83 (0.17:7.18) | ||
M (IQR) | 0.77 (0.53-1.08) | 0.92 (0.56-1.31) | 0.83 (0.55-1.14) | ||
Gμ ±SD | 0.743 ±1.74 | 0.854 ±1.93 | 0.796 ±1.84 | ||
Platelets (*1000/uL) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.017 |
μ ±SD | 183.81 ±77.8 | 207.29 ±91.3 | 195.29 ±85.3 | ||
M (min:max) | 176 (14:470) | 201 (5:630) | 184 (5:630) | ||
M (IQR) | 176 (128-219) | 201 (148.25-254) | 184 (135-238) | ||
Gμ ±SD | 167.65 ±1.58 | 183.67 ±1.81 | 175.29 ±1.7 | ||
Hemoglobin (g/dL) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.272 |
μ ±SD | 13.26 ±1.72 | 12.88 ±2.08 | 13.07 ±1.91 | ||
M (min:max) | 13.5 (7.2:16.8) | 13.2 (5.8:16.9) | 13.4 (5.8:16.9) | ||
M (IQR) | 13.5 (12-14.4) | 13.2 (11.7-14.4) | 13.4 (11.9-14.4) | ||
Gμ ±SD | 13.14 ±1.15 | 12.69 ±1.2 | 12.92 ±1.18 | ||
Fibrinogen (mg/dL) | N (%) | 95 (84.1%) | 89 (82.4%) | 184 (83.3%) | MW: p=0.767 |
μ ±SD | 522.34 ±153.7 | 529.88 ±186.3 | 525.99 ±169.8 | ||
M (min:max) | 505.21 (231.02:947.04) | 502.83 (142.83:937.64) | 504.02 (142.83:947.04) | ||
M (IQR) | 505.21 (386.47-626.36) | 502.83 (403.01-631.11) | 504.02 (396.78-631.11) | ||
Gμ ±SD | 500.41 ±1.34 | 494.94 ±1.47 | 497.75 ±1.41 | ||
D-dimer (mg/L) | N (%) | 104 (92.0%) | 97 (89.8%) | 201 (91.0%) | MW: p=0.018 |
μ ±SD | 1.35 ±4.62 | 4.04 ±12.4 | 2.65 ±9.29 | ||
M (min:max) | 0.66 (0.19:46.92) | 0.86 (0.19:80) | 0.72 (0.19:80) | ||
M (IQR) | 0.66 (0.42-1.06) | 0.86 (0.43-1.7) | 0.72 (0.43-1.39) | ||
Gμ ±SD | 0.699 ±2.3 | 1.09 ±3.51 | 0.866 ±2.94 | ||
CRP (mg/dL) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.225 |
μ ±SD | 9.83 ±7.48 | 11.73 ±9.78 | 10.76 ±8.71 | ||
M (min:max) | 7.76 (0.09:32.99) | 9.82 (0.06:54.35) | 8.78 (0.06:54.35) | ||
M (IQR) | 7.76 (4.06-14.73) | 9.82 (4.19-17.35) | 8.78 (4.17-15.2) | ||
Gμ ±SD | 6.50 ±3.05 | 7.26 ±3.4 | 6.86 ±3.22 | ||
CRP >7.5 mg/dL | 60 (53.1%) | 69 (63.9%) | 129 (58.4%) | OR=0.64 [0.37, 1.10] (p=0.133) | |
PCT (ng/mL) | N (%) | 17 (15.0%) | 29 (26.9%) | 46 (20.8%) | MW: p=0.206 |
μ ±SD | 1.13 ±3.86 | 0.561 ±0.743 | 0.772 ±2.39 | ||
M (min:max) | 0.15 (0.05:16.08) | 0.19 (0.05:2.68) | 0.16 (0.05:16.08) | ||
M (IQR) | 0.15 (0.08-0.24) | 0.19 (0.14-0.56) | 0.16 (0.08-0.41) | ||
Gμ ±SD | 0.184 ±4.02 | 0.271 ±3.34 | 0.235 ±3.58 | ||
Ferritin (ng/mL) | N (%) | 108 (95.6%) | 102 (94.4%) | 210 (95.0%) | MW: p=0.921 |
μ ±SD | 695.01 ±564.6 | 831.79 ±915.3 | 761.44 ±756.8 | ||
M (min:max) | 526.85 (41.9:2852) | 534.85 (40.5:4815) | 526.85 (40.5:4815) | ||
M (IQR) | 526.85 (332.75-900.55) | 534.85 (226.88-1013.8) | 526.85 (274.75-939.45) | ||
Gμ ±SD | 508.88 ±2.32 | 491.14 ±2.96 | 500.18 ±2.63 | ||
ALT (U/L) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.479 |
μ ±SD | 45.45 ±34.5 | 106.82 ±634.4 | 75.44 ±444.1 | ||
M (min:max) | 35 (10:193) | 33 (6:6624) | 34 (6:6624) | ||
M (IQR) | 35 (22-59) | 33 (18.75-56) | 34 (21-59) | ||
Gμ ±SD | 36.55 ±1.9 | 35.50 ±2.51 | 36.03 ±2.2 | ||
AST (U/L) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.037 |
μ ±SD | 49.73 ±28.4 | 165.80 ±1205.2 | 106.45 ±842.8 | ||
M (min:max) | 41 (17:198) | 35 (9:12563) | 39 (9:12563) | ||
M (IQR) | 41 (32-59) | 35 (26-52) | 39 (28-56) | ||
Gμ ±SD | 43.69 ±1.64 | 40.26 ±2.37 | 41.98 ±2.02 | ||
LDH (U/L) | N (%) | 111 (98.2%) | 103 (95.4%) | 214 (96.8%) | MW: p=0.198 |
μ ±SD | 376.10 ±141.4 | 358.84 ±157.6 | 367.79 ±149.3 | ||
M (min:max) | 363 (166:1060) | 320 (145:986) | 359 (145:1060) | ||
M (IQR) | 363 (275.5-447) | 320 (238.5-465) | 359 (248.25-452.5) | ||
Gμ ±SD | 352.95 ±1.43 | 328.51 ±1.52 | 340.97 ±1.47 | ||
μ ±SD = Mean ± standard deviation; M (min:max) = Median (min:max); MW = Mann-Whitney Test; OR = odds-ratio [95% CI] and p value from Fisher test); * custom text |
Day 0
Variable | Details | 2021 | 2020 | Total | Statistics |
Year | 113 (51.1%) | 108 (48.9%) | 221 | ||
IL6 (pg/mL) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.003 |
μ ±SD | 137.55 ±101.3 | 127.41 ±141.9 | 132.59 ±122.7 | ||
M (min:max) | 108.42 (3.64:557.41) | 74.48 (10.27:747.68) | 94.42 (3.64:747.68) | ||
M (IQR) | 108.42 (73.58-173.83) | 74.48 (48.53-146.78) | 94.42 (58.42-159.42) | ||
Gμ ±SD | 103.18 ±2.42 | 84.81 ±2.39 | 93.75 ±2.41 | ||
IL6 >150 pg/mL | 37 (32.7%) | 26 (24.1%) | 63 (28.5%) | OR=1.54 [0.85, 2.77] (p=0.180) | |
WBC (*1000/uL) | N (%) | 97 (85.8%) | 100 (92.6%) | 197 (89.1%) | MW: p=0.240 |
μ ±SD | 8.37 ±4.19 | 8.86 ±3.99 | 8.62 ±4.09 | ||
M (min:max) | 7.4 (1.7:22.7) | 8.34 (1:19) | 7.6 (1:22.7) | ||
M (IQR) | 7.4 (5.55-10.4) | 8.34 (5.97-11.62) | 7.6 (5.7-11.1) | ||
Gμ ±SD | 7.45 ±1.63 | 7.90 ±1.68 | 7.67 ±1.65 | ||
PMN (*1000/uL) | N (%) | 97 (85.8%) | 100 (92.6%) | 197 (89.1%) | MW: p=0.533 |
μ ±SD | 7.01 ±3.95 | 7.23 ±3.7 | 7.12 ±3.82 | ||
M (min:max) | 6.4 (0.71:19.94) | 6.65 (0.77:15.73) | 6.44 (0.71:19.94) | ||
M (IQR) | 6.4 (4.35-9.03) | 6.65 (4.25-9.84) | 6.44 (4.35-9.28) | ||
Gμ ±SD | 5.97 ±1.83 | 6.21 ±1.81 | 6.09 ±1.82 | ||
Lymphocytes (*1000/uL) | N (%) | 97 (85.8%) | 100 (92.6%) | 197 (89.1%) | MW: p=0.058 |
μ ±SD | 0.862 ±0.706 | 1.04 ±0.932 | 0.952 ±0.832 | ||
M (min:max) | 0.78 (0.15:6.72) | 0.89 (0.17:8.72) | 0.83 (0.15:8.72) | ||
M (IQR) | 0.78 (0.51-1.01) | 0.89 (0.52-1.34) | 0.83 (0.51-1.15) | ||
Gμ ±SD | 0.732 ±1.73 | 0.841 ±1.89 | 0.785 ±1.82 | ||
Platelets (*1000/uL) | N (%) | 97 (85.8%) | 100 (92.6%) | 197 (89.1%) | MW: p=0.079 |
μ ±SD | 215.03 ±99.9 | 231.08 ±95.6 | 223.18 ±97.8 | ||
M (min:max) | 187 (50:594) | 214 (2:596) | 204 (2:596) | ||
M (IQR) | 187 (151-253) | 214 (168.5-300) | 204 (159-282) | ||
Gμ ±SD | 195.34 ±1.55 | 205.87 ±1.86 | 200.61 ±1.71 | ||
Hemoglobin (g/dL) | N (%) | 97 (85.8%) | 100 (92.6%) | 197 (89.1%) | MW: p=0.101 |
μ ±SD | 12.92 ±1.62 | 12.39 ±1.96 | 12.65 ±1.81 | ||
M (min:max) | 13.1 (9.2:15.8) | 12.6 (6.3:15.8) | 12.9 (6.3:15.8) | ||
M (IQR) | 13.1 (11.8-14) | 12.6 (11.4-13.8) | 12.9 (11.5-13.9) | ||
Gμ ±SD | 12.82 ±1.14 | 12.22 ±1.19 | 12.51 ±1.17 | ||
Fibrinogen (mg/dL) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.409 |
μ ±SD | 555.53 ±159.4 | 537.07 ±176.3 | 546.51 ±167.7 | ||
M (min:max) | 560.03 (285:1101.74) | 521.65 (142.83:937.64) | 534.23 (142.83:1101.74) | ||
M (IQR) | 560.03 (419.08-667.11) | 521.65 (422.71-619.9) | 534.23 (422.3-645) | ||
Gμ ±SD | 533.32 ±1.33 | 506.28 ±1.43 | 519.93 ±1.39 | ||
D-dimer (mg/L) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.026 |
μ ±SD | 1.20 ±1.71 | 5.96 ±14.7 | 3.53 ±10.6 | ||
M (min:max) | 0.7 (0.19:13.7) | 0.92 (0.19:80) | 0.82 (0.19:80) | ||
M (IQR) | 0.7 (0.44-1.27) | 0.92 (0.47-2.74) | 0.82 (0.46-1.68) | ||
Gμ ±SD | 0.788 ±2.27 | 1.39 ±4.39 | 1.04 ±3.39 | ||
CRP (mg/dL) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.558 |
μ ±SD | 10.91 ±7.65 | 10.96 ±9.47 | 10.93 ±8.56 | ||
M (min:max) | 9.09 (0.46:33.2) | 9.22 (0.82:54.35) | 9.12 (0.46:54.35) | ||
M (IQR) | 9.09 (5.33-15.1) | 9.22 (4.77-13.36) | 9.12 (4.85-14.57) | ||
Gμ ±SD | 8.02 ±2.44 | 7.86 ±2.37 | 7.94 ±2.4 | ||
CRP >7.5 mg/dL | 68 (60.2%) | 60 (55.6%) | 128 (57.9%) | OR=1.21 [0.71, 2.06] (p=0.499) | |
PCT (ng/mL) | N (%) | 40 (35.4%) | 32 (29.6%) | 72 (32.6%) | MW: p=0.025 |
μ ±SD | 0.564 ±2.52 | 0.553 ±0.957 | 0.559 ±1.97 | ||
M (min:max) | 0.11 (0.05:16.08) | 0.16 (0.05:4.65) | 0.14 (0.05:16.08) | ||
M (IQR) | 0.11 (0.07-0.2) | 0.16 (0.11-0.46) | 0.14 (0.08-0.26) | ||
Gμ ±SD | 0.139 ±2.85 | 0.239 ±3.29 | 0.177 ±3.12 | ||
Ferritin (ng/mL) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.885 |
μ ±SD | 683.69 ±473.7 | 823.51 ±793.2 | 752.02 ±652.0 | ||
M (min:max) | 584 (72.5:2750) | 614.55 (48.9:4214) | 584 (48.9:4214) | ||
M (IQR) | 584 (368.8-895.1) | 614.55 (257.5-968.65) | 584 (303.7-938.5) | ||
Gμ ±SD | 537.26 ±2.1 | 540.95 ±2.62 | 539.06 ±2.35 | ||
ALT (U/L) | N (%) | 92 (81.4%) | 92 (85.2%) | 184 (83.3%) | MW: p=0.228 |
μ ±SD | 57.85 ±46.4 | 73.12 ±224.9 | 65.48 ±162.1 | ||
M (min:max) | 42 (8:254) | 41 (6:2168) | 42 (6:2168) | ||
M (IQR) | 42 (26.75-70.75) | 41 (22.75-64) | 42 (25-66.25) | ||
Gμ ±SD | 44.59 ±2.05 | 39.47 ±2.37 | 41.95 ±2.21 | ||
AST (U/L) | N (%) | 92 (81.4%) | 93 (86.1%) | 185 (83.7%) | MW: p=0.007 |
μ ±SD | 52.48 ±27.2 | 57.06 ±118.4 | 54.78 ±85.9 | ||
M (min:max) | 45.5 (19:136) | 34 (9:1136) | 41 (9:1136) | ||
M (IQR) | 45.5 (32.75-63.5) | 34 (24-59) | 41 (27-61) | ||
Gμ ±SD | 46.53 ±1.63 | 37.74 ±2.1 | 41.88 ±1.89 | ||
LDH (U/L) | N (%) | 113 (100%) | 106 (98.1%) | 219 (99.1%) | MW: p=0.291 |
μ ±SD | 408.80 ±151.6 | 405.46 ±203.9 | 407.18 ±178.4 | ||
M (min:max) | 387 (166:941) | 373.5 (145:1365) | 379 (145:1365) | ||
M (IQR) | 387 (302-492) | 373.5 (265-486.75) | 379 (289.5-490) | ||
Gμ ±SD | 383.24 ±1.43 | 366.69 ±1.55 | 375.14 ±1.49 | ||
μ ±SD = Mean ± standard deviation; M (min:max) = Median (min:max); MW = Mann-Whitney Test; OR = odds-ratio [95% CI] and p value from Fisher test); * custom text |
Day 1
Variable | Details | 2021 | 2020 | Total | Statistics |
Year | 113 (51.1%) | 108 (48.9%) | 221 | ||
IL6 (pg/mL) | N (%) | 35 (31.0%) | 36 (33.3%) | 71 (32.1%) | MW: p=0.579 |
μ ±SD | 359.87 ±310.5 | 432.50 ±400.9 | 396.70 ±358.5 | ||
M (min:max) | 265.39 (14.89:1226.06) | 264.36 (1.2:1414.34) | 265.39 (1.2:1414.34) | ||
M (IQR) | 265.39 (135.52-561.16) | 264.36 (141.34-728.36) | 265.39 (135.52-582.1) | ||
Gμ ±SD | 221.33 ±3.16 | 244.42 ±3.94 | 232.75 ±3.53 | ||
IL6 >150 pg/mL | 24 (68.6%) | 25 (69.4%) | 49 (69.0%) | OR=0.96 [0.35, 2.63] (p>0.999) | |
WBC (*1000/uL) | N (%) | 77 (68.1%) | 76 (70.4%) | 153 (69.2%) | MW: p=0.550 |
μ ±SD | 6.96 ±3.94 | 7.15 ±4.01 | 7.06 ±3.96 | ||
M (min:max) | 6.38 (1.1:19.65) | 6.86 (1:22.37) | 6.68 (1:22.37) | ||
M (IQR) | 6.38 (4.15-8.6) | 6.86 (4.65-8.79) | 6.68 (4.3-8.7) | ||
Gμ ±SD | 5.95 ±1.79 | 6.14 ±1.79 | 6.05 ±1.79 | ||
PMN (*1000/uL) | N (%) | 78 (69.0%) | 77 (71.3%) | 155 (70.1%) | MW: p=0.889 |
μ ±SD | 5.79 ±3.8 | 5.75 ±3.83 | 5.77 ±3.8 | ||
M (min:max) | 5.05 (0.61:17.9) | 5.54 (0.6:21.45) | 5.11 (0.6:21.45) | ||
M (IQR) | 5.05 (3.2-7.56) | 5.54 (3.13-7.39) | 5.11 (3.17-7.43) | ||
Gμ ±SD | 4.67 ±1.99 | 4.62 ±2.03 | 4.65 ±2.01 | ||
Lymphocytes (*1000/uL) | N (%) | 78 (69.0%) | 77 (71.3%) | 155 (70.1%) | MW: p=0.039 |
μ ±SD | 0.783 ±0.67 | 0.942 ±0.621 | 0.862 ±0.649 | ||
M (min:max) | 0.61 (0.17:5.38) | 0.81 (0.22:3.55) | 0.7 (0.17:5.38) | ||
M (IQR) | 0.61 (0.47-0.89) | 0.81 (0.48-1.12) | 0.7 (0.47-1.03) | ||
Gμ ±SD | 0.647 ±1.79 | 0.78 ±1.87 | 0.71 ±1.84 | ||
Platelets (*1000/uL) | N (%) | 78 (69.0%) | 77 (71.3%) | 155 (70.1%) | MW: p=0.735 |
μ ±SD | 255.55 ±108.9 | 245.01 ±103.3 | 250.32 ±105.9 | ||
M (min:max) | 240.5 (67:608) | 238 (4:563) | 238 (4:608) | ||
M (IQR) | 240.5 (177.75-310.75) | 238 (158-324) | 238 (169-324) | ||
Gμ ±SD | 233.36 ±1.55 | 214.57 ±1.92 | 223.83 ±1.74 | ||
Hemoglobin (g/dL) | N (%) | 78 (69.0%) | 77 (71.3%) | 155 (70.1%) | MW: p=0.303 |
μ ±SD | 12.80 ±1.58 | 12.38 ±2.1 | 12.59 ±1.86 | ||
M (min:max) | 13.05 (9.2:16.6) | 12.6 (5.9:16.9) | 12.8 (5.9:16.9) | ||
M (IQR) | 13.05 (11.62-13.88) | 12.6 (11.1-14) | 12.8 (11.2-13.9) | ||
Gμ ±SD | 12.70 ±1.13 | 12.18 ±1.21 | 12.44 ±1.17 | ||
Fibrinogen (mg/dL) | N (%) | 42 (37.2%) | 46 (42.6%) | 88 (39.8%) | MW: p=0.658 |
μ ±SD | 570.16 ±120.9 | 557.50 ±149.1 | 563.54 ±135.7 | ||
M (min:max) | 569.62 (316.63:893.98) | 555.49 (197.66:923.43) | 564.5 (197.66:923.43) | ||
M (IQR) | 569.62 (494.74-657.49) | 555.49 (456.86-650.01) | 564.5 (461.1-657.49) | ||
Gμ ±SD | 557.54 ±1.24 | 536.45 ±1.34 | 546.41 ±1.29 | ||
D-dimer (mg/L) | N (%) | 76 (67.3%) | 67 (62.0%) | 143 (64.7%) | MW: p=0.031 |
μ ±SD | 2.97 ±8.26 | 8.14 ±16.7 | 5.39 ±13.2 | ||
M (min:max) | 0.94 (0.21:63.9) | 1.83 (0.19:80) | 1.11 (0.19:80) | ||
M (IQR) | 0.94 (0.54-2.12) | 1.83 (0.62-5.55) | 1.11 (0.58-3.12) | ||
Gμ ±SD | 1.17 ±2.97 | 2.16 ±4.83 | 1.56 ±3.93 | ||
CRP (mg/dL) | N (%) | 87 (77.0%) | 87 (80.6%) | 174 (78.7%) | MW: p=0.126 |
μ ±SD | 10.04 ±6.74 | 8.96 ±7.46 | 9.50 ±7.11 | ||
M (min:max) | 8.58 (0.66:33.67) | 6.27 (0.66:47.74) | 7.96 (0.66:47.74) | ||
M (IQR) | 8.58 (4.71-13.55) | 6.27 (3.74-13.34) | 7.96 (4.22-13.61) | ||
Gμ ±SD | 7.82 ±2.18 | 6.34 ±2.47 | 7.04 ±2.33 | ||
CRP >7.5 mg/dL | 51 (58.6%) | 41 (47.1%) | 92 (52.9%) | OR=1.59 [0.87, 2.89] (p=0.172) | |
PCT (ng/mL) | N (%) | 8 (7.1%) | 14 (13.0%) | 22 (10.0%) | MW: p=0.305 |
μ ±SD | 1.13 ±2.34 | 0.27 ±0.289 | 0.581 ±1.43 | ||
M (min:max) | 0.23 (0.06:6.87) | 0.1 (0.05:0.81) | 0.12 (0.05:6.87) | ||
M (IQR) | 0.23 (0.09-0.65) | 0.1 (0.06-0.44) | 0.12 (0.07-0.55) | ||
Gμ ±SD | 0.304 ±4.87 | 0.156 ±2.94 | 0.199 ±3.63 | ||
Ferritin (ng/mL) | N (%) | 73 (64.6%) | 72 (66.7%) | 145 (65.6%) | MW: p=0.842 |
μ ±SD | 906.71 ±672.9 | 1013.08 ±825.8 | 959.53 ±752.0 | ||
M (min:max) | 765.9 (116.6:3369) | 769.85 (119.6:3278) | 765.9 (116.6:3369) | ||
M (IQR) | 765.9 (433.5-1133.6) | 769.85 (409.98-1263.07) | 765.9 (420.1-1198.5) | ||
Gμ ±SD | 709.50 ±2.07 | 734.99 ±2.3 | 722.04 ±2.18 | ||
ALT (U/L) | N (%) | 64 (56.6%) | 66 (61.1%) | 130 (58.8%) | MW: p=0.419 |
μ ±SD | 55.41 ±37.9 | 77.05 ±125.8 | 66.39 ±93.8 | ||
M (min:max) | 49 (6:183) | 53.5 (6:1014) | 52 (6:1014) | ||
M (IQR) | 49 (24.75-72) | 53.5 (28.5-90.25) | 52 (26-78.5) | ||
Gμ ±SD | 43.80 ±2.05 | 50.65 ±2.31 | 47.15 ±2.18 | ||
AST (U/L) | N (%) | 64 (56.6%) | 67 (62.0%) | 131 (59.3%) | MW: p=0.791 |
μ ±SD | 51.61 ±31.4 | 54.24 ±43.2 | 52.95 ±37.8 | ||
M (min:max) | 44.5 (13:207) | 43 (10:298) | 44 (10:298) | ||
M (IQR) | 44.5 (31-67.5) | 43 (28-66.5) | 44 (31-67.5) | ||
Gμ ±SD | 44.29 ±1.75 | 43.79 ±1.89 | 44.03 ±1.82 | ||
LDH (U/L) | N (%) | 60 (53.1%) | 55 (50.9%) | 115 (52.0%) | MW: p=0.039 |
μ ±SD | 485.23 ±170.8 | 431.44 ±180.5 | 459.50 ±176.8 | ||
M (min:max) | 457 (198:954) | 385 (210:1019) | 425 (198:1019) | ||
M (IQR) | 457 (351.25-573.25) | 385 (291.5-534.5) | 425 (319.5-552.5) | ||
Gμ ±SD | 457.41 ±1.41 | 400.36 ±1.46 | 429.18 ±1.44 | ||
μ ±SD = Mean ± standard deviation; M (min:max) = Median (min:max); MW = Mann-Whitney Test; OR = odds-ratio [95% CI] and p value from Fisher test); * custom text |
Day 3
Variable | Details | 2021 | 2020 | Total | Statistics |
Year | 113 (51.1%) | 108 (48.9%) | 221 | ||
IL6 (pg/mL) | N (%) | 32 (28.3%) | 44 (40.7%) | 76 (34.4%) | MW: p=0.098 |
μ ±SD | 261.12 ±245.4 | 490.51 ±474.6 | 393.92 ±408.7 | ||
M (min:max) | 180.54 (11.82:1079.38) | 258 (13.78:1590.64) | 219.89 (11.82:1590.64) | ||
M (IQR) | 180.54 (88.67-369.42) | 258 (96.93-789.27) | 219.89 (93.22-594.97) | ||
Gμ ±SD | 153.61 ±3.34 | 257.04 ±3.67 | 206.95 ±3.59 | ||
IL6 >150 pg/mL | 18 (56.2%) | 29 (65.9%) | 47 (61.8%) | OR=0.67 [0.26, 1.70] (p=0.475) | |
WBC (*1000/uL) | N (%) | 86 (76.1%) | 83 (76.9%) | 169 (76.5%) | MW: p=0.799 |
μ ±SD | 8.22 ±5.13 | 8.19 ±4.74 | 8.21 ±4.93 | ||
M (min:max) | 7.03 (2.1:27.75) | 7.8 (1.1:24.29) | 7.5 (1.1:27.75) | ||
M (IQR) | 7.03 (4.84-9.95) | 7.8 (4.75-10.36) | 7.5 (4.8-10) | ||
Gμ ±SD | 7.01 ±1.75 | 6.92 ±1.85 | 6.96 ±1.8 | ||
PMN (*1000/uL) | N (%) | 86 (76.1%) | 83 (76.9%) | 169 (76.5%) | MW: p=0.881 |
μ ±SD | 6.68 ±4.94 | 6.46 ±4.54 | 6.57 ±4.73 | ||
M (min:max) | 5.64 (0.89:26.42) | 5.63 (0.63:22.94) | 5.63 (0.63:26.42) | ||
M (IQR) | 5.64 (3.51-7.88) | 5.63 (3.13-8.53) | 5.63 (3.28-8.24) | ||
Gμ ±SD | 5.33 ±1.98 | 5.05 ±2.11 | 5.19 ±2.04 | ||
Lymphocytes (*1000/uL) | N (%) | 86 (76.1%) | 83 (76.9%) | 169 (76.5%) | MW: p=0.399 |
μ ±SD | 0.967 ±0.53 | 1.23 ±1.1 | 1.10 ±0.866 | ||
M (min:max) | 0.82 (0.17:3.25) | 0.89 (0.24:7.18) | 0.85 (0.17:7.18) | ||
M (IQR) | 0.82 (0.6-1.32) | 0.89 (0.55-1.39) | 0.85 (0.58-1.35) | ||
Gμ ±SD | 0.84 ±1.73 | 0.951 ±1.99 | 0.893 ±1.87 | ||
Platelets (*1000/uL) | N (%) | 86 (76.1%) | 83 (76.9%) | 169 (76.5%) | MW: p=0.039 |
μ ±SD | 294.40 ±102.7 | 259.13 ±107.6 | 277.08 ±106.3 | ||
M (min:max) | 284.5 (65:647) | 257 (4:539) | 272 (4:647) | ||
M (IQR) | 284.5 (224.25-351.5) | 257 (171.5-337) | 272 (203-344) | ||
Gμ ±SD | 275.96 ±1.46 | 227.98 ±1.89 | 251.25 ±1.7 | ||
Hemoglobin (g/dL) | N (%) | 86 (76.1%) | 83 (76.9%) | 169 (76.5%) | MW: p=0.139 |
μ ±SD | 12.94 ±1.65 | 12.40 ±1.98 | 12.67 ±1.83 | ||
M (min:max) | 12.95 (8.8:17.2) | 12.9 (6.7:16.3) | 12.9 (6.7:17.2) | ||
M (IQR) | 12.95 (12-14.17) | 12.9 (11.15-13.8) | 12.9 (11.4-13.9) | ||
Gμ ±SD | 12.83 ±1.14 | 12.23 ±1.19 | 12.53 ±1.17 | ||
Fibrinogen (mg/dL) | N (%) | 47 (41.6%) | 54 (50.0%) | 101 (45.7%) | MW: p=0.806 |
μ ±SD | 406.72 ±112.6 | 408.98 ±111.9 | 407.93 ±111.6 | ||
M (min:max) | 390.97 (198.94:784.56) | 396.37 (158.21:667.11) | 395.62 (158.21:784.56) | ||
M (IQR) | 390.97 (332.04-471.2) | 396.37 (339-466.97) | 395.62 (335.35-466.97) | ||
Gμ ±SD | 392.19 ±1.31 | 393.19 ±1.34 | 392.73 ±1.33 | ||
D-dimer (mg/L) | N (%) | 77 (68.1%) | 78 (72.2%) | 155 (70.1%) | MW: p=0.157 |
μ ±SD | 4.29 ±11.1 | 4.23 ±7.35 | 4.26 ±9.38 | ||
M (min:max) | 0.93 (0.19:71.96) | 1.19 (0.19:40.42) | 1.03 (0.19:71.96) | ||
M (IQR) | 0.93 (0.58-1.84) | 1.19 (0.59-4.49) | 1.03 (0.58-2.57) | ||
Gμ ±SD | 1.27 ±3.56 | 1.68 ±3.59 | 1.46 ±3.59 | ||
CRP (mg/dL) | N (%) | 89 (78.8%) | 88 (81.5%) | 177 (80.1%) | MW: p=0.355 |
μ ±SD | 2.83 ±2.0 | 2.87 ±2.95 | 2.85 ±2.51 | ||
M (min:max) | 2.48 (0.11:8.2) | 1.96 (0.11:18.39) | 2.1 (0.11:18.39) | ||
M (IQR) | 2.48 (1.08-4.19) | 1.96 (1.1-3.46) | 2.1 (1.09-3.97) | ||
Gμ ±SD | 1.99 ±2.68 | 1.87 ±2.64 | 1.93 ±2.65 | ||
CRP >7.5 mg/dL | 3 (3.4%) | 7 (8.0%) | 10 (5.6%) | OR=0.40 [0.10, 1.61] (p=0.212) | |
PCT (ng/mL) | N (%) | 6 (5.3%) | 8 (7.4%) | 14 (6.3%) | MW: p=0.136 |
μ ±SD | 0.095 ±0.0409 | 0.635 ±1.12 | 0.404 ±0.869 | ||
M (min:max) | 0.1 (0.05:0.15) | 0.14 (0.08:3.33) | 0.11 (0.05:3.33) | ||
M (IQR) | 0.1 (0.06-0.12) | 0.14 (0.1-0.46) | 0.11 (0.09-0.16) | ||
Gμ ±SD | 0.0883 ±1.59 | 0.244 ±3.77 | 0.158 ±3.13 | ||
Ferritin (ng/mL) | N (%) | 68 (60.2%) | 81 (75.0%) | 149 (67.4%) | MW: p=0.606 |
μ ±SD | 744.91 ±517.5 | 893.31 ±897.2 | 825.58 ±749.5 | ||
M (min:max) | 648.75 (68.1:2694) | 682.9 (95.4:5943) | 682.9 (68.1:5943) | ||
M (IQR) | 648.75 (366.7-981.7) | 682.9 (355.7-1044.2) | 682.9 (355.7-1021.7) | ||
Gμ ±SD | 572.78 ±2.21 | 641.74 ±2.25 | 609.30 ±2.23 | ||
ALT (U/L) | N (%) | 77 (68.1%) | 65 (60.2%) | 142 (64.3%) | MW: p=0.610 |
μ ±SD | 82.49 ±70.5 | 80.23 ±72.5 | 81.46 ±71.2 | ||
M (min:max) | 60 (7:418) | 54 (13:395) | 59 (7:418) | ||
M (IQR) | 60 (38-96) | 54 (27-106) | 59 (36-101.75) | ||
Gμ ±SD | 61.76 ±2.16 | 58.07 ±2.23 | 60.04 ±2.19 | ||
AST (U/L) | N (%) | 76 (67.3%) | 64 (59.3%) | 140 (63.3%) | MW: p=0.441 |
μ ±SD | 55.95 ±30.8 | 53.64 ±34.7 | 54.89 ±32.5 | ||
M (min:max) | 46.5 (13:156) | 46 (10:191) | 46 (10:191) | ||
M (IQR) | 46.5 (35-70.5) | 46 (28-71.5) | 46 (33-70.5) | ||
Gμ ±SD | 48.74 ±1.7 | 44.16 ±1.9 | 46.59 ±1.79 | ||
LDH (U/L) | N (%) | 54 (47.8%) | 58 (53.7%) | 112 (50.7%) | MW: p=0.157 |
μ ±SD | 504.56 ±235.8 | 441.62 ±207.8 | 471.96 ±223.0 | ||
M (min:max) | 430 (205:1285) | 394.5 (175:1168) | 417 (175:1285) | ||
M (IQR) | 430 (320-682.25) | 394.5 (311-518) | 417 (313-583) | ||
Gμ ±SD | 456.22 ±1.57 | 402.00 ±1.54 | 427.29 ±1.56 | ||
μ ±SD = Mean ± standard deviation; M (min:max) = Median (min:max); MW = Mann-Whitney Test; OR = odds-ratio [95% CI] and p value from Fisher test); * custom text |
Day 7
Variable | Details | 2021 | 2020 | Total | Statistics |
Year | 113 (51.1%) | 108 (48.9%) | 221 | ||
IL6 (pg/mL) | N (%) | 34 (30.1%) | 41 (38.0%) | 75 (33.9%) | MW: p=0.795 |
μ ±SD | 279.51 ±446.8 | 231.28 ±265.6 | 253.14 ±357.4 | ||
M (min:max) | 95.54 (13.23:1633) | 117.17 (7.5:1318.2) | 112.21 (7.5:1633) | ||
M (IQR) | 95.54 (64.35-240.05) | 117.17 (59.37-334.89) | 112.21 (61.25-256.53) | ||
Gμ ±SD | 121.11 ±3.51 | 131.34 ±3.03 | 126.60 ±3.22 | ||
IL6 >150 pg/mL | 13 (38.2%) | 18 (43.9%) | 31 (41.3%) | OR=0.79 [0.31, 2.00] (p=0.646) | |
WBC (*1000/uL) | N (%) | 83 (73.5%) | 81 (75.0%) | 164 (74.2%) | MW: p=0.116 |
μ ±SD | 10.32 ±5.42 | 9.14 ±5.02 | 9.74 ±5.25 | ||
M (min:max) | 9.9 (1.78:27.44) | 8.66 (2.02:25.71) | 9.25 (1.78:27.44) | ||
M (IQR) | 9.9 (6.05-13.15) | 8.66 (5-11.24) | 9.25 (5.85-12.45) | ||
Gμ ±SD | 8.89 ±1.78 | 7.87 ±1.76 | 8.37 ±1.78 | ||
PMN (*1000/uL) | N (%) | 83 (73.5%) | 80 (74.1%) | 163 (73.8%) | MW: p=0.037 |
μ ±SD | 8.16 ±5.05 | 6.80 ±5.0 | 7.50 ±5.06 | ||
M (min:max) | 7.94 (0.79:24.71) | 6.08 (0.74:23.78) | 6.88 (0.74:24.71) | ||
M (IQR) | 7.94 (4.71-10.72) | 6.08 (2.92-9.29) | 6.88 (3.52-9.96) | ||
Gμ ±SD | 6.52 ±2.1 | 5.15 ±2.22 | 5.81 ±2.17 | ||
Lymphocytes (*1000/uL) | N (%) | 83 (73.5%) | 81 (75.0%) | 164 (74.2%) | MW: p=0.600 |
μ ±SD | 1.41 ±1.07 | 1.61 ±1.51 | 1.51 ±1.3 | ||
M (min:max) | 1.17 (0.25:8.16) | 1.22 (0.2:10.61) | 1.2 (0.2:10.61) | ||
M (IQR) | 1.17 (0.78-1.78) | 1.22 (0.76-1.94) | 1.2 (0.77-1.8) | ||
Gμ ±SD | 1.15 ±1.89 | 1.22 ±2.09 | 1.19 ±1.99 | ||
Platelets (*1000/uL) | N (%) | 83 (73.5%) | 81 (75.0%) | 164 (74.2%) | MW: p<0.001 |
μ ±SD | 295.14 ±87.0 | 238.10 ±108.2 | 266.97 ±101.8 | ||
M (min:max) | 296 (54:502) | 221 (3:489) | 268 (3:502) | ||
M (IQR) | 296 (237.5-353) | 221 (170-310) | 268 (197.75-330.5) | ||
Gμ ±SD | 280.30 ±1.42 | 203.56 ±2.03 | 239.33 ±1.78 | ||
Hemoglobin (g/dL) | N (%) | 83 (73.5%) | 81 (75.0%) | 164 (74.2%) | MW: p=0.011 |
μ ±SD | 13.23 ±1.54 | 12.49 ±1.79 | 12.86 ±1.7 | ||
M (min:max) | 13.3 (9.5:15.9) | 12.6 (7.9:16.2) | 13 (7.9:16.2) | ||
M (IQR) | 13.3 (12.4-14.4) | 12.6 (11.3-13.8) | 13 (11.8-14.1) | ||
Gμ ±SD | 13.14 ±1.13 | 12.35 ±1.16 | 12.75 ±1.15 | ||
Fibrinogen (mg/dL) | N (%) | 39 (34.5%) | 48 (44.4%) | 87 (39.4%) | MW: p=0.755 |
μ ±SD | 277.84 ±80.9 | 291.75 ±88.0 | 285.51 ±84.7 | ||
M (min:max) | 268.69 (100.62:461) | 269.24 (135.5:526.68) | 268.74 (100.62:526.68) | ||
M (IQR) | 268.69 (228.55-346.05) | 269.24 (231.14-324.53) | 268.74 (230.72-332.74) | ||
Gμ ±SD | 264.91 ±1.39 | 279.94 ±1.33 | 273.10 ±1.36 | ||
D-dimer (mg/L) | N (%) | 72 (63.7%) | 73 (67.6%) | 145 (65.6%) | MW: p=0.121 |
μ ±SD | 2.82 ±7.47 | 3.22 ±5.47 | 3.02 ±6.52 | ||
M (min:max) | 1 (0.19:60.22) | 1.39 (0.19:36.54) | 1.15 (0.19:60.22) | ||
M (IQR) | 1 (0.48-2.11) | 1.39 (0.61-3.92) | 1.15 (0.53-2.96) | ||
Gμ ±SD | 1.14 ±3.17 | 1.51 ±3.27 | 1.31 ±3.24 | ||
CRP (mg/dL) | N (%) | 71 (62.8%) | 75 (69.4%) | 146 (66.1%) | MW: p=0.250 |
μ ±SD | 0.453 ±0.366 | 0.906 ±1.71 | 0.686 ±1.27 | ||
M (min:max) | 0.39 (0.04:1.79) | 0.42 (0.08:9.5) | 0.39 (0.04:9.5) | ||
M (IQR) | 0.39 (0.2-0.54) | 0.42 (0.22-0.73) | 0.39 (0.2-0.63) | ||
Gμ ±SD | 0.329 ±2.36 | 0.441 ±2.85 | 0.383 ±2.64 | ||
CRP >7.5 mg/dL | 0 | 2 (2.7%) | 2 (1.4%) | OR=0.21 [0.01, 4.36] (p=0.497) | |
PCT (ng/mL) | N (%) | 11 (10.2%) | 11 (10.2%) | ||
μ ±SD | 0.53 ±1.2 | 0.53 ±1.2 | |||
M (min:max) | 0.05 (0.05:4.09) | 0.05 (0.05:4.09) | |||
M (IQR) | 0.05 (0.05-0.24) | 0.05 (0.05-0.24) | |||
Gμ ±SD | 0.138 ±4.34 | 0.138 ±4.34 | |||
Ferritin (ng/mL) | N (%) | 60 (53.1%) | 70 (64.8%) | 130 (58.8%) | MW: p=0.365 |
μ ±SD | 639.17 ±369.8 | 668.10 ±695.6 | 654.74 ±567.1 | ||
M (min:max) | 598.5 (83.7:1827) | 503.45 (47.4:4894) | 547.5 (47.4:4894) | ||
M (IQR) | 598.5 (357.85-819.22) | 503.45 (262.08-793.25) | 547.5 (291.45-804.8) | ||
Gμ ±SD | 526.98 ±1.97 | 464.72 ±2.39 | 492.49 ±2.2 | ||
ALT (U/L) | N (%) | 113 (100%) | 108 (100%) | 221 (100%) | MW: p=0.520 |
μ ±SD | 87.24 ±69.2 | 86.81 ±96.9 | 87.03 ±83.7 | ||
M (min:max) | 68 (13:359) | 62.5 (14:852) | 65 (13:852) | ||
M (IQR) | 68 (44-99) | 62.5 (44.75-90.5) | 65 (44-94) | ||
Gμ ±SD | 67.93 ±2.03 | 65.60 ±1.99 | 66.78 ±2.0 | ||
AST (U/L) | N (%) | 113 (100%) | 107 (99.1%) | 220 (99.5%) | MW: p=0.061 |
μ ±SD | 45.91 ±24.9 | 52.82 ±28.6 | 49.27 ±26.9 | ||
M (min:max) | 42 (10:146) | 49 (8:168) | 45 (8:168) | ||
M (IQR) | 42 (27-59) | 49 (32-65) | 45 (29-62.25) | ||
Gμ ±SD | 39.92 ±1.72 | 45.80 ±1.74 | 42.68 ±1.73 | ||
LDH (U/L) | N (%) | 48 (42.5%) | 57 (52.8%) | 105 (47.5%) | MW: p=0.969 |
μ ±SD | 411.44 ±184.5 | 418.40 ±202.6 | 415.22 ±193.7 | ||
M (min:max) | 379 (164:1050) | 354 (141:1083) | 358 (141:1083) | ||
M (IQR) | 379 (272.5-505.5) | 354 (283-479) | 358 (274-503) | ||
Gμ ±SD | 376.23 ±1.53 | 378.68 ±1.55 | 377.56 ±1.54 | ||
μ ±SD = Mean ± standard deviation; M (min:max) = Median (min:max); MW = Mann-Whitney Test; OR = odds-ratio [95% CI] and p value from Fisher test); * custom text |
Predictor | F | Epsilon | p | ges |
(Intercept) | 161.55 | 0.000 | 0.47 | |
Deceased | 2.46 | 0.120 | 0.01 | |
Time | 172.21 | 0.71 | 0.000 | 0.41 |
Deceased x Time | 1.48 | 0.71 | 0.222 | 0.01 |
Pairwise | Admission | Day 0 | Day 1 | Day 3 | Day 7 |
Admission | p=0.396 | p=0.580 | p<0.001 | p<0.001 | |
Day 0 | p=0.396 | p=0.021 | p<0.001 | p<0.001 | |
Day 1 | p=0.580 | p=0.021 | p<0.001 | p<0.001 | |
Day 3 | p<0.001 | p<0.001 | p<0.001 | p<0.001 | |
Day 7 | p<0.001 | p<0.001 | p<0.001 | p<0.001 |
Predictor | F | Epsilon | p | ges |
(Intercept) | 444.20 | 0.000 | 0.93 | |
Deceased | 5.28 | 0.035 | 0.13 | |
Time | 4.36 | 0.54 | 0.018 | 0.12 |
Deceased x Time | 0.94 | 0.54 | 0.404 | 0.03 |
Pairwise | Admission | Day 0 | Day 1 | Day 3 | Day 7 |
Admission | p=0.042 | p=0.003 | p=0.042 | p=0.110 | |
Day 0 | p=0.042 | p=0.042 | p=0.187 | p>0.999 | |
Day 1 | p=0.003 | p=0.042 | p>0.999 | p=0.093 | |
Day 3 | p=0.042 | p=0.187 | p>0.999 | p=0.187 | |
Day 7 | p=0.110 | p>0.999 | p=0.093 | p=0.187 |
 | Deceased | ||
---|---|---|---|
Predictors | Odds Ratios | CI | p |
(Intercept) | 0.00 | 0.00 – 0.03 | <0.001 |
Day 3: CRP >7.5 mg/dL: da | 16.60 | 3.07 – 108.96 | 0.002 |
log2: Admission IL6 (pg/mL) |
1.23 | 0.85 – 1.85 | 0.285 |
Lung damage >40%: yes | 11.68 | 2.05 – 224.98 | 0.024 |
TCZ >3 days after admission: yes |
3.76 | 1.06 – 15.14 | 0.047 |
Cardiovascular comorbidities (>2): yes |
3.65 | 1.06 – 12.53 | 0.037 |
Observations | 154 | ||
R2 Tjur | 0.245 |
 | Deceased | ||
---|---|---|---|
Predictors | Odds Ratios | CI | p |
(Intercept) | 0.00 | 0.00 – 0.02 | <0.001 |
Age (years) | 1.25 | 0.81 – 1.97 | 0.318 |
log2: Admission IL6 (pg/mL) |
1.27 | 0.93 – 1.79 | 0.139 |
Lung damage >40%: yes | 15.64 | 2.94 – 292.81 | 0.010 |
TCZ >3 days after admission: yes |
3.51 | 1.22 – 10.89 | 0.023 |
Cardiovascular comorbidities (>2): yes |
3.64 | 1.21 – 11.14 | 0.021 |
Observations | 190 | ||
R2 Tjur | 0.164 |
 | ICU admission | ||
---|---|---|---|
Predictors | Odds Ratios | CI | p |
(Intercept) | 0.29 | 0.02 – 3.76 | 0.346 |
Age (years) | 0.67 | 0.48 – 0.92 | 0.016 |
log2: Admission IL6 (pg/mL) |
1.11 | 0.89 – 1.40 | 0.346 |
Lung damage >40%: yes | 10.93 | 4.08 – 38.27 | <0.001 |
TCZ >3 days after admission: yes |
1.37 | 0.64 – 2.97 | 0.422 |
Cardiovascular comorbidities (>2): yes |
3.40 | 1.38 – 8.75 | 0.009 |
Observations | 190 | ||
R2 Tjur | 0.197 |
 | Deceased | ||
---|---|---|---|
Predictors | Odds Ratios | CI | p |
(Intercept) | 0.00 | 0.00 – 0.00 | <0.001 |
log2: IL6 (pg/mL) | 1.84 | 1.18 – 3.03 | 0.010 |
Age (years) | 1.07 | 1.02 – 1.12 | 0.004 |
Lung damage >40%: yes | 7.01 | 1.20 – 134.06 | 0.074 |
Sepsis/Pneumonia: yes | 19.59 | 3.79 – 131.34 | 0.001 |
ICU admission: yes | 3.61 | 1.19 – 11.56 | 0.025 |
TCZ >3 days after admission: yes |
2.34 | 0.81 – 7.14 | 0.121 |
Observations | 221 | ||
R2 Tjur | 0.354 |
 | Deceased | ||
---|---|---|---|
Predictors | Odds Ratios | CI | p |
(Intercept) | 0.00 | 0.00 – 0.00 | <0.001 |
Day 3: CRP >7.5 mg/dL: da | 13.11 | 2.25 – 89.52 | 0.005 |
log2: Day 0 IL6 (pg/mL) | 1.77 | 1.10 – 3.05 | 0.026 |
Lung damage >40%: yes | 11.61 | 2.03 – 223.76 | 0.025 |
TCZ >3 days after admission: yes |
3.14 | 1.03 – 10.78 | 0.052 |
Cardiovascular comorbidities (>2): yes |
3.81 | 1.14 – 12.82 | 0.028 |
Observations | 177 | ||
R2 Tjur | 0.283 |
model: | qualitative time | continuous time | ||
IL6 (pg/mL) | Statistic | p-value | Statistic | p-value |
Deceased | 12.4 | p<0.001 | 10.0 | p=0.002 |
Time | 55.0 | p<0.001 | 10.7 | p=0.001 |
Pairwise | Admission | Day 0 | Day 1 | Day 3 | Day 7 |
Admission | p<0.001 | p<0.001 | p<0.001 | p<0.001 | |
Day 0 | p<0.001 | p<0.001 | p<0.001 | p=0.226 | |
Day 1 | p<0.001 | p<0.001 | p=0.480 | p<0.001 | |
Day 3 | p<0.001 | p<0.001 | p=0.480 | p<0.001 | |
Day 7 | p<0.001 | p=0.226 | p<0.001 | p<0.001 |
model: | qualitative time | continuous time | ||
WBC (*1000/uL) | Statistic | p-value | Statistic | p-value |
Deceased | 20.6 | p<0.001 | 20.3 | p<0.001 |
Time | 22.7 | p<0.001 | 61.8 | p<0.001 |
Pairwise | Admission | Day 0 | Day 1 | Day 3 | Day 7 |
Admission | p<0.001 | p=0.845 | p=0.017 | p<0.001 | |
Day 0 | p<0.001 | p<0.001 | p=0.845 | p=0.039 | |
Day 1 | p=0.845 | p<0.001 | p=0.002 | p<0.001 | |
Day 3 | p=0.017 | p=0.845 | p=0.002 | p<0.001 | |
Day 7 | p<0.001 | p=0.039 | p<0.001 | p<0.001 |
model: | qualitative time | continuous time | ||
PMN (*1000/uL) | Statistic | p-value | Statistic | p-value |
Deceased | 22.1 | p<0.001 | 22.0 | p<0.001 |
Time | 13.7 | p<0.001 | 18.1 | p<0.001 |
Pairwise | Admission | Day 0 | Day 1 | Day 3 | Day 7 |
Admission | p<0.001 | p>0.999 | p=0.089 | p=0.012 | |
Day 0 | p<0.001 | p<0.001 | p=0.066 | p>0.999 | |
Day 1 | p>0.999 | p<0.001 | p=0.066 | p=0.007 | |
Day 3 | p=0.089 | p=0.066 | p=0.066 | p=0.042 | |
Day 7 | p=0.012 | p>0.999 | p=0.007 | p=0.042 |
model: | qualitative time | continuous time | ||
Lymphocytes (*1000/uL) | Statistic | p-value | Statistic | p-value |
Deceased | 16.6 | p<0.001 | 15.9 | p<0.001 |
Time | 40.0 | p<0.001 | 121.9 | p<0.001 |
Pairwise | Admission | Day 0 | Day 1 | Day 3 | Day 7 |
Admission | p>0.999 | p>0.999 | p=0.001 | p<0.001 | |
Day 0 | p>0.999 | p>0.999 | p=0.001 | p<0.001 | |
Day 1 | p>0.999 | p>0.999 | p<0.001 | p<0.001 | |
Day 3 | p=0.001 | p=0.001 | p<0.001 | p<0.001 | |
Day 7 | p<0.001 | p<0.001 | p<0.001 | p<0.001 |
model: | qualitative time | continuous time | ||
Platelets (*1000/uL) | Statistic | p-value | Statistic | p-value |
Deceased | 0.0722 | p=0.788 | 0.0168 | p=0.897 |
Time | 66.2437 | p<0.001 | 59.8098 | p<0.001 |
Pairwise | Admission | Day 0 | Day 1 | Day 3 | Day 7 |
Admission | p<0.001 | p<0.001 | p<0.001 | p<0.001 | |
Day 0 | p<0.001 | p<0.001 | p<0.001 | p<0.001 | |
Day 1 | p<0.001 | p<0.001 | p<0.001 | p=0.237 | |
Day 3 | p<0.001 | p<0.001 | p<0.001 | p=0.104 | |
Day 7 | p<0.001 | p<0.001 | p=0.237 | p=0.104 |
model: | qualitative time | continuous time | ||
Hemoglobin (g/dL) | Statistic | p-value | Statistic | p-value |
Deceased | 4.1 | p=0.044 | 4.210 | p=0.041 |
Time | 13.0 | p<0.001 | 0.191 | p=0.663 |
Pairwise | Admission | Day 0 | Day 1 | Day 3 | Day 7 |
Admission | p<0.001 | p<0.001 | p=0.003 | p=0.236 | |
Day 0 | p<0.001 | p=0.500 | p=0.315 | p=0.078 | |
Day 1 | p<0.001 | p=0.500 | p=0.267 | p=0.267 | |
Day 3 | p=0.003 | p=0.315 | p=0.267 | p=0.267 | |
Day 7 | p=0.236 | p=0.078 | p=0.267 | p=0.267 |
model: | qualitative time | continuous time | ||
Fibrinogen (mg/dL) | Statistic | p-value | Statistic | p-value |
Deceased | 1.53 | p=0.217 | 1.84 | p=0.176 |
Time | 131.80 | p<0.001 | 265.90 | p<0.001 |
Pairwise | Admission | Day 0 | Day 1 | Day 3 | Day 7 |
Admission | p=0.499 | p=0.648 | p<0.001 | p<0.001 | |
Day 0 | p=0.499 | p=0.026 | p<0.001 | p<0.001 | |
Day 1 | p=0.648 | p=0.026 | p<0.001 | p<0.001 | |
Day 3 | p<0.001 | p<0.001 | p<0.001 | p<0.001 | |
Day 7 | p<0.001 | p<0.001 | p<0.001 | p<0.001 |
model: | qualitative time | continuous time | ||
D-dimer (mg/L) | Statistic | p-value | Statistic | p-value |
Deceased | 19.1 | p<0.001 | 18.55530 | p<0.001 |
Time | 13.4 | p<0.001 | 0.00959 | p=0.922 |
Pairwise | Admission | Day 0 | Day 1 | Day 3 | Day 7 |
Admission | p=0.002 | p<0.001 | p<0.001 | p=0.059 | |
Day 0 | p=0.002 | p=0.010 | p=0.015 | p=0.822 | |
Day 1 | p<0.001 | p=0.010 | p=0.727 | p=0.015 | |
Day 3 | p<0.001 | p=0.015 | p=0.727 | p=0.003 | |
Day 7 | p=0.059 | p=0.822 | p=0.015 | p=0.003 |
model: | qualitative time | continuous time | ||
CRP (mg/dL) | Statistic | p-value | Statistic | p-value |
Deceased | 8.88 | p=0.003 | 7.67 | p=0.006 |
Time | 563.95 | p<0.001 | 892.73 | p<0.001 |
Pairwise | Admission | Day 0 | Day 1 | Day 3 | Day 7 |
Admission | p=0.059 | p=0.530 | p<0.001 | p<0.001 | |
Day 0 | p=0.059 | p<0.001 | p<0.001 | p<0.001 | |
Day 1 | p=0.530 | p<0.001 | p<0.001 | p<0.001 | |
Day 3 | p<0.001 | p<0.001 | p<0.001 | p<0.001 | |
Day 7 | p<0.001 | p<0.001 | p<0.001 | p<0.001 |
model: | qualitative time | continuous time | ||
PCT (ng/mL) | Statistic | p-value | Statistic | p-value |
Deceased | 8.49 | p=0.004 | 9.10 | p=0.003 |
Time | 2.26 | p=0.069 | 3.64 | p=0.059 |
Pairwise | Admission | Day 0 | Day 1 | Day 3 | Day 7 |
Admission | p>0.999 | p>0.999 | p>0.999 | p>0.999 | |
Day 0 | p>0.999 | p=0.395 | p>0.999 | p>0.999 | |
Day 1 | p>0.999 | p=0.395 | p>0.999 | ||
Day 3 | p>0.999 | p>0.999 | p>0.999 | p>0.999 | |
Day 7 | p>0.999 | p>0.999 | p>0.999 |
model: | qualitative time | continuous time | ||
Ferritin (ng/mL) | Statistic | p-value | Statistic | p-value |
Deceased | 5.27 | p=0.023 | 4.99 | p=0.026 |
Time | 16.95 | p<0.001 | 29.76 | p<0.001 |
Pairwise | Admission | Day 0 | Day 1 | Day 3 | Day 7 |
Admission | p=0.053 | p<0.001 | p=0.169 | p=0.341 | |
Day 0 | p=0.053 | p<0.001 | p=0.728 | p<0.001 | |
Day 1 | p<0.001 | p<0.001 | p=0.004 | p<0.001 | |
Day 3 | p=0.169 | p=0.728 | p=0.004 | p<0.001 | |
Day 7 | p=0.341 | p<0.001 | p<0.001 | p<0.001 |
model: | qualitative time | continuous time | ||
ALT (U/L) | Statistic | p-value | Statistic | p-value |
Deceased | 0.0202 | p=0.887 | 0.0196 | p=0.889 |
Time | 53.3582 | p<0.001 | 136.4781 | p<0.001 |
Pairwise | Admission | Day 0 | Day 1 | Day 3 | Day 7 |
Admission | p=0.020 | p=0.019 | p<0.001 | p<0.001 | |
Day 0 | p=0.020 | p=0.178 | p<0.001 | p<0.001 | |
Day 1 | p=0.019 | p=0.178 | p<0.001 | p<0.001 | |
Day 3 | p<0.001 | p<0.001 | p<0.001 | p=0.007 | |
Day 7 | p<0.001 | p<0.001 | p<0.001 | p=0.007 |
model: | qualitative time | continuous time | ||
AST (U/L) | Statistic | p-value | Statistic | p-value |
Deceased | 3.691 | p=0.056 | 3.669 | p=0.057 |
Time | 0.774 | p=0.542 | 0.396 | p=0.529 |
Pairwise | Admission | Day 0 | Day 1 | Day 3 | Day 7 |
Admission | p>0.999 | p>0.999 | p>0.999 | p>0.999 | |
Day 0 | p>0.999 | p>0.999 | p>0.999 | p>0.999 | |
Day 1 | p>0.999 | p>0.999 | p>0.999 | p>0.999 | |
Day 3 | p>0.999 | p>0.999 | p>0.999 | p=0.041 | |
Day 7 | p>0.999 | p>0.999 | p>0.999 | p=0.041 |
model: | qualitative time | continuous time | ||
LDH (U/L) | Statistic | p-value | Statistic | p-value |
Deceased | 39.8 | p<0.001 | 40.4945 | p<0.001 |
Time | 11.0 | p<0.001 | 0.0072 | p=0.932 |
Pairwise | Admission | Day 0 | Day 1 | Day 3 | Day 7 |
Admission | p<0.001 | p<0.001 | p<0.001 | p=0.917 | |
Day 0 | p<0.001 | p=0.899 | p=0.279 | p=0.279 | |
Day 1 | p<0.001 | p=0.899 | p=0.917 | p=0.032 | |
Day 3 | p<0.001 | p=0.279 | p=0.917 | p=0.004 | |
Day 7 | p=0.917 | p=0.279 | p=0.032 | p=0.004 |
.